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i
Nitric oxide (NO) is a critical mediator of a variety of biological functions,
'
including vascular and muscle relaxation, platelet aggregation, neuronal-cell function, 
microbicidal and tumoricidal activity, and a range of immunopathologies. NO is derived 
from L-arginine and molecular oxygen in a reaction catalysed by NO synthase (NOS).
Three isoforms of NOS have been identified; neuronal constitutive NOS (ncNOS), 
endothelial constitutive NOS (ecNOS), and inducible NOS (iNOS). ncNOS and ecNOS 
are calcium-dependent, present constitutively in a variety of tissues and produce 
physiological concentrations of NO. However, large amounts NO are produced by iNOS 
which are expressed in cells such as macrophage after stimulation with a number of 
cytokines, including interferon-gamma (IFN-y), tumour necrosis factor-alpha (TNF-a), 
and bacterial lipopolysaccharide (LPS). Findings of iNOS biological functions are based 
mainly on experiments using L-arginine analogues such as L-N ^ monomethyl arginine 
(L-NMMA) which competitively inhibits NO Synthase. These inhibitors are not NOS 
isoform selective and have differential bioavailability, and hence often render 
interpretation of results difficult. To directly define the iNOS biological functions, I 
constructed a strain of iNOS gene targeted mice.
The first step of a gene targeting experiment is typically cDNA cloning and 
sequencing. A cDNA library was constructed in the vector X ZAPII using mRNA isolated 
from J774 macrophages activated with IFN-y and LPS. Six independent positive colonies 
were found in the screen with both 5' and 3' specific probes and were subcloned in 
pBluescript. A full-length iNOS cDNA was constructed using the clones isolated from the 
library. Double strand cDNA sequence analysis showed that the J774 iNOS clone was 
identical to that of the Raw 264.7 macrophages iNOS cDNA sequence.
A replacement-type targeting construct was prepared from 129/sv genomic DNA. 
A single targeted clone was identified amongst 636 screened after two independent 
electroporations of the CGR8  embryonic stem cell line. Gene replacement was detected by
both 5' and 3' specific external probes. Five of ten chimeras generated gave germ line 
transmission. No homozygous mice were found by Southern blot analysis with 5' and 3' 
external probe in the offspring from heterozygous mice (FI) breedings. The iNOS gene 
had been altered by replacement with gene targeting construct and 5' iNOS gene 
translocation which could be detected by internal probe Southern blot analysis. Using the 
internal probe, mutant homozygous, heterozygous and wild-type mice were found in the 
offspring from heterozygous breedings. The ratio of these three genotypes was 21:47:25. 
Northern blot analysis with 5' iNOS cDNA probe showed that a large messenger 
appeared in the macrophages of homozygous mice when the cells were activated with 
IFN-y and LPS in vitro. However there was no detectable iNOS protein translation by 
western blot analysis using monoclonal or polyclonal anti-iNOS antibodies. No nitrite 
(N02“) was produced from macrophages of iNOS mutant mice 24 hours after stimulation 
with IFN-y and LPS. By 72 hours, however, a low level of nitrite was detectable in the 
supernatant of cells from the mutant mice. This may reflect the upregulation of 
constitutive NOS by LPS.
The homozygous mice are viable, fertile and without evident histopathological 
abnormalities. Spleen cells from iNOS mutant mice had similar proportion of T cells 
compared with wild-type mice and also gave similar levels of IFN-y and IL-4 production 
and proliferations after stimulation with concanavalin A. The wild-type and heterozygous 
mice were highly resistant ioLeishmania major infection, and all animals achieved 
spontaneous healing after footpad infection. In contrast, the iNOS mutant mice were 
uniformly susceptible to the infection. Spleen cells from mutant mice infected with L. 
major contained a significantly higher proportion of CD3+ and CD3+CD4+ T cells and 
produced more IFN-y but less IL-4 than those from similarly infected wild-type or 
heterozygous mice. I
The capacity of these mice to develop local inflammation was also investigated. 
The mutant mice developed significantly less footpad swelling than wild-type mice after 
injection with caiTageenin. Spleen cells from carrageenin-treated mutant mice also had a
19 I
higher proportion of CD3+, CD3+CD4+ and CD3+CD8+ T cells than those from
processing and presentation. This is highlighted by the recent demonstration that human
20
5
similarly treated wild-type mice. They also had a higher proliferation rate and produced 
more IFN-y than those from the wild-type mice when stimulated with concanavalin A in 
vitro.
f
The mutant mice were more resistant to LPS-induced death than wild-type mice, 
which developed severe loss of mass when injected intraperitoneally with LPS. The
I
mutant mice showed a transient loss of mass but no further sign of ill health. In contrast, 
wild-type mice underwent substantial loss of mass with about 50% mortality by 72 hours 
after injection with 12.5 mg/kg body mass.
Mice deficient in iNOS provide a powerful tool that will not only facilitate formal 
demonstration of the effect or roles of NO in microbicidal and tumoricidal activity,
transplantation and in a range of immunopathologies, but also help to define the
■
involvement of NO in immune regulation, immunological tolerance and antigen
!
monocyte/macrophages expressed iNOS and generated NO in quantities sufficient to kill 
.
Leishmania parasites.
I
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Chapter 1
General Introduction
21
Part I. Cytokine Inducible Nitric Oxide Synthase
1 .1 .  Nitric oxide (NO) and nitric oxide synthase
1.1.1. The historical perspective
The quest to identify the so-called endothelium-derived relaxing factor (EDRF) 
(Furchgott, et a t, 1980) led to the discovery in the vasculature of an enzyme, nitric oxide 
synthase (NOS) (reviewed in Moncada, et aL, 1993). The early studies on EDRF 
demonstrated that EDRF was a very short-lived substance, with half-life of only seconds 
in oxygenated physiological salt solutions (Griffith, et ah, 1984; Cocks, et ah, 1985). 
The effects of EDRF were shown to be inhibited by haemoglobin (Hb), methylene blue 
(Martin, et ah, 1985) and other agents such as dithiothreitol and hydroquinone (Griffith, 
et ah, 1984) and to be mediated by stimulation of the soluble guanylate cyclase with the 
consequent elevation of intracellular cyclic GMP (cGMP) levels (Rapoport, et ah, 1983). 
Superoxide anions (O2") contribute to the instability of EDRF, because the effects of 
EDRF were prolonged by the addition of SOD (Gryglewski, et ah, 1986a; Rubanyi, et 
ah, 1986) and inhibited by Fe^+ (Gryglewski et ah, 1986b). In 1987, Palmer and Ignarro 
independently suggested that endothelium-derived relaxing factor (EDRF) was either NO 
or an NO-related molecule. The first direct demonstration of the release of NO by 
mammalian cells was in experiments on vascular tone and platelet aggregation (Palmer, et 
ah, 1987; Moncada, et ah, 1990).
Meanwhile, an independent line of scientists found that when human were fed a 
low nitrite diet, endogenously synthesized NO3" was excreted (Green, et ah, 1981). 
Similar results were obtained with germ-free rats, thus ruling out the participation of gut 
microflora in the reaction. During the course of the human experiments, one of the 
subjects coincidentally became ill and showed a large increase in urinary NO3 - excretion. 
Subsequent experiments in rats showed that the urinary NO3 " levels could be elevated 
about tenfold when fever was induced by an intraperitoneal injection of Escherichia CoU 
(E. coll ) lipopolysaccharide (LPS). These findings suggested that this elevated synthesis
22
might be related to the immunostimulatlon known to be brought about by LPS. The LPS- 
induced synthesis NO in vivo was then reproduced by stimulation of murine peritoneal 
macrophages in culture (Stuehr, et al. 1985). Some cytokines could also stimulate 
macrophages to carry out this synthesis. Subsequent experiments showed that the major 
lymphokine involved in the synthesis response was interferon-y (IFN-y) (Stuehr, et at.
1987). The stimulatory effects of LPS and IFN-y were synergistic and a elevator of 
murine macrophage cell that were found to respond in a similar way to LPS and IFN-y 
(reviewed in Marietta, et aL, 1989). Subsequent studies showed that NO is synthesised 
from the semi-essential amino acid L-arginine by NO synthase (Hibbss, et at. 19S7;
Stuehr, et al. 1987; Iyengar, et al. 1987; Palmer, et al. 1988). This process can be 
inhibited by certain guanidino-substituted arginine analogues, including N^-monomethyl- 
L-arginine (L-NMMA) (Hibbs, et al., 1987).
1.1.2. Chaiacteristic of thiee forms of nitric oxide synthase
There are at least three distinct forms of NO synthase; One is the inducible nitric 
oxide synthase (iNOS) which was first found in the murine macrophages. Under basal 
conditions, iNOS activity in macrophages is negligible, while on stimulation with IFN-y 
and LPS, macrophages can produce massive enhancement of NO synthase in a few hours 
(Nathan and Hibbs, 1991). iNOS (NOS-II) is independent of Ca^+. The other two forms 
of NOS were identified in blood vessels and neurones, they are constitutively expressed 
and their activity depends on elevated levels of Ca^+. Recently they have been named 
ecNOS (NOS-III) and ncNOS(NOS-I) (reviewed by Nathan and Xie, 1994). All three 
NO synthases are flavoproteins containing bound flavin mononucleotide (FMN) and 
flavin adenine dinucleotide (FAD). They are dependent on NADPH as a co-factor and
. Si
tetrahydrobiopterin (BH4) enhances enzyme activity (Palmer, et a l, 1989; Hevel, et al.
1991; Mayer, et a l, 1991; Schmidt, et a l, 1992; Bredt, et a l, 1992; Tayeh, et a l, 1989;
:
Kwon, et a l, 1989) The derived sequence of ncNOS from rat brain was the first to note 
that the C terminus showed a significant homology to NADPH cytochrome P-450
23
reductase (Bredt, et al.,\99V). The nucleotide binding sequence as well as those
il
sequences associated with FAD and FMN binding were highly conserved when compared 
with P-450 reductase from rat liver. This same homology has been observed in all the 
reported NOS sequences (Fig. 1.1). The N terminus in all sequences of three forms 
shows a great deal of similarity suggesting a common functional role, most likely related 
to the arginine binding site and catalysis (reviewed by Marietta, 1993). A comparison 
with other arginine binding enzymes, however, has not provided any answers 
(Lowenstein, et al. 1992).
So far, genes encoding the three distinct NOS isoforms have been cloned and 
located to different human chromosomes (ncNOS: 12q24.2; ecNOS: 7q35-36; iNOS:
17cen-ql2) (reviewed by Nathan and Xie, 1994). Expressions of three genes are vary in 
subcellular location, ncNOS was found originally in neuro-systems but also in 
extraneuronal sites such as skeletal muscle, pancreas, and kidney (Kobzik, et aL, 1994;
Lukic, et aL, 1991; Mundel, et aL, 1992; Imai, et aL, 1992). The isoform first purified
.
and cloned from endothelial cells is also expressed in neurons (Dinerman, et aL, 1994).
The isoform first purified and cloned from macrophages is inducible in cell types from all 
branches of the histogenetic tree, among them neurons and endothelial cells (Oswald, et 
aL, 1994). Recent reports showed that one or more isoforms could also express in the 
same cell type (Reiling, et sL, 1994; Dusting, et aL, 1995).
1.1.3. The functions of NO
Small amounts of NO are generated by the two constitutiviy expressed NOS 
(ncNOOS and neNOS) enzymes, while high levels of NO are produced by inducible 
NOS. NO produced from the NOS enzymes have manifold functions. In many systems, 
NO derives from two or more different cellular sources, forming networks of paracrine 
communication. Neurones produce NO to regulate transmitter release of adjacent neurones 
and also to match cerebral blood flow with neuronal activity. Endothelium-derived NO is 
vasoprotective by potentially antagonizing smooth muscle contraction and all stages of 
platelet activation. NO is a double-edged sword, it is essential as a messenger or 
modulator, and for host defence against pathogens. However, in excessive amounts it can
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also lead to a range of immunopathologies. In this study, I shall concentrate on the iNOS 
using gene-targeting to demonstrate its role in number of biological functions.
1.2.1. iNOS cDNA cloning from mouse and human
1.2.2. iNOS expression
1 .2 .  Inducible nitric oxide synthase (iNOS)
At the beginning of this study, several groups reported iNOS cDNA molecular
cloning from murine macrophage RAW 264.7 cells (Xie, et aL, 1992; Lyons, et aL,
■
1992; and Lowenstein, et aL, 1992) and also from rat vascular smooth muscle cells 
(Nunokawa, et aL, 1993). Human iNOS from different cell types (chondrocyte, 
hepatocyte, and smooth muscle) have also been subsequently cloned (Charles, et aL, 
1993; Geller, et a l, 1993; Sherman, et aL, 1993). During this study, I cloned the iNOS 
cDNA from murine macrophage J774 cells (Moss, et aL, 1995).
Although resting unstimulated cells express little iNOS, the capacity to express 
this enzyme exists in nearly every tissue in the body. The list of cell types capable of 
expressing iNOS now includes macrophages, neutrophils, kératinocytes, respiratory 
epithelium, retinal pigment epithelium, renal tubular epithelium, myoepithelium, 
adenocarcinomas, hepatocytes, pancreatic islet cells, endothelium, endocardium, 
mesangial cells, cardiac myocytes, vascular smooth muscle, uterine and fallopian tube 
smooth muscle, fibroblasts, chondrocytes, osteoclasts, neurons and astrocytes 
(Lorsbach, et al., 1993; Cunha, et al., 1993; Geller, et al., 1993; Nussler, et al., 1992;
Wood, et al., 1993; Eizirik, et al., 1993; Corbett, et al., 1993; Nakayama, et al., 1992;
Koide, et al., 1993; Galea, et al., 1992; Goureau, et al., 1993; Heck, et a i, 1992). Many 
agents have the ability to induce iNOS expression in various cell types to different levels.
Most of these described so far are microbes, microbial products, or inflammatory
-
cytokines, and there is often strong synergy between these agents. For example, murine 
macrophages express high levels of iNOS upon exposure to LPS and this is elevated by 
the addition of IFN-y or TNF-a (Hibbs, et al., 1990).
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1.23. Regulation of the biosynthesis of nitric oxide from iNOS
Biosynthesis of NO from iNOS is regulated at different levels: genomic level, 
transcriptional control, post-transcriptional/translational control, and post-translational 
control.
Genomic level. So far, naturally occurring defects of the iNOS gene have not been 
reported. One observation showed that the chromosomal position of human iNOS is 
syngenic to a region of rat chromosome 10 implicated in spontaneous hypertension (P.A, 
Marsden, et a l,  1994). A phenotypic deficiency in iNOS expression resulting from 
disrupting each of three other genes has been reported: IFN-y (Dalton, et al., 1993), one 
chain of the IFN-y receptor (Huang, et al., 1993) and interferon regulatory factor-1 
(Kamijo, et al., 1994). However, IFN-y is not the only stimulator for the induction of 
iNOS gene expression. Knowledges on the regulation of iNOS expression at a genomic 
level is currently obscure.
Transcriptional control. Both mouse and human iNOS promoters have been 
identified (Xie, et al., 1993; Lowenstein, et al., 1993, Chartrain, et a l,  1994). By 
transfection of murine macrophage RAW 264.7 cells with the promoter-reporter gene 
cassettes, the function of promoter/enhancer elements was shown for both murine (Xie, et 
al., 1993) and human genes (reviewed by Marris, et al., 1994). In the murine iNOS 
promoter, there are at least 24 oligonucleotide elements homologous to consensus 
sequences for the binding of transcription factors involved in the inducibility of other 
genes by cytokines or bacterial products. Transcription factors are translocated and 
phosphorylated before binding on the iNOS promoter. IRF-1 is one of the crucial 
translation factors
Post-transcriptional and translational control. Stability of mRNA is a major control 
point in the regulation iNOS. For example, TGF-p suppresses macrophage iNOS 
expression via decreased iNOS mRNA stability and translational efficiency and by 
decreased stability of iNOS protein but does not alter iNOS transcription (Vodovotz, et
27
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al., 1993).These effects may be cell-type specific, as TGF-p attenuates iNOS mRNA
latter cells (Imai, et al., 1994), while in mouse macrophages, the same protein synthesis 
inhibitor prevents expression of iNOS mRNA
1 , 3 .  The role of iNOS
28
I
t
Iinduction in RAW 264.7 cells but enhances induction in Swiss 3T3 cells (reviewed by 
Morris, et al., 1994). Conversely, Cycloheximide markedly stabilises iNOS mRNA in the
Post-translational control. Unlike the other two NOSs (ncNOS and ecNOS), 
iNOS contains calmodulin which is tightly bound to each subunit of the enzyme, so that 
iNOS is Ca^+ independent (Stuehr, et al. 1991). iNOS protein is phosphorylated after 
translation, however no effect of phosphorylation on iNOS activity has been reported. L- 
arginine is the only physiological nitrogen donor for the NOS-catalysed reaction, 
regulation of availability of this essential substrate by arginine synthesis and uptake could 
determine cellular rates of NO synthesis (Nussler, et a l, 1994, Bogle, et a l, 1994). BH4 
is synthesised from GTP. Levels can also be influenced by the activities of recycling or 
salvage pathways that convert the oxidised forms, quinoid-dihydrobiopterin and 
dihydrobiopterin, respectively to BH4 . GTP-cyclohydrolase I (GTP-CH) levels are 
absent or very low in unstimulated cells, but it is strongly co-induced with iNOS in these 
cells by cytokines and LPS. However, it is unknown whether the activities of the 
recycling or salvage pathways for BH4 synthesis are co-regulated with iNOS expression 
(reviewed by Morris, et al., 1994). Electrons donated by NADPH are essential for NO 
formation by NOS. The requirement of NOS for NADPH implies that the activities of 
metabolic-pathways that generate or compete for this co-factor could play an important 
role in determining rates of cellular NO production. Although there have been relatively 
few studies on this point, observations that the activity of the NADPH-generating pentose 
phosphate pathway, and of the rate-limiting enzyme glucose-6 -phosphate dehydrogenase 
(G-6 -PDH), in particular, is correlated with NO production in some cells support this 
possibility.
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1.3.1. Non-specific defence
It has been known for many years that micro-organisms, or microbial 
components, can increase host resistance to the growth of tumours by an antigen-specific 
step that involves sensitised lymphocytes and by a non-specific step that is mediated by 
activated macrophages (Alexander, et al., 1971; Keller, et a l, 1971; Hibbs, et al., 1972). 
Present evidence suggests that this non-specific immunity is associated with the induction 
of NOS. If this the case, NO-dependent non-specific immunity is a general phenomenon
involving not only the reticuloendothelial system but also nonreticuloendothelial cells such 
as hepatocytes (Nussler, et al., 1992), vascular smooth muscle (Rees, et al., 1990) and 
the vascular endothelium (Radomski, et al., 1990), in all of which the inducible NOS has 
been detected. The role of the lung and liver in NO-dependent non-specific immunity 
appears to be crucial, since both organs are strategically placed in the circulation to serve 
as immunologic filters. Lymphocytes release NO (Kirk, et al., 1990), and murine 
macrophages reduce lymphocyte activation by a NO-dependent mechanism (Hoffman, et 
al,, 1990; Albina, et a l, 1991). Furthermore, NO has been shown to be involved in 
immune rejection of allografted organs (Langrehr, et a l,  1991), graft-versus-host 
disease, and sepsis (reviewed by Schmidt, et a l, 1994). These data suggest that NO is 
involved in specific immunity, but its precise role is not yet clear.
,
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NO has also been shown to be important in parasitic infections and has been most 
extensively studied in leishmaniasis. Mouse peritoneal macrophages stimulated, in vitro, 
with IFN-y in the presence of LPS are efficient in killing Leishmania and this 
leishmanicidal activity can be completely abrogated by L-NMMA (Fig. 1.2) in a dose- 
dependent manner, but not by its D-enantiomer (D-NMMA) (Green, et a l, 1990; Liew, et 
a l, 1990). Furthermore, culture supernatants of macrophages activated by IFN-y contain 
significantly increased levels of NO2" (Stuehr, et a l, 1987; Ding, et a l, 1988; Drapier, et 
a l,  1988), the production of which is also inhibited by L-NMMA (Liew, et a l, 1990). 
Leishmania major (L.major) promastigotes are killed when incubated, in vitro, at room
s
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NO Synthase
(a) 02 + L-arginine -< \ NO- + Citruiine
L-NMMA
S N=0
/  \  /
(b) NO ■ + enyzme[4Fe-4S] — enyzme Fe
S ^ N = 0
(c) Oa- + NO ONOO +H : 
HO" + NO2 "
ONOOH
NOi + H-"
Fig. 1.2. The generation of NO and the possible mechanisms of its anti-microbial effects, (a) N O  
synthesis is catalysed by NO synthase and can be competitively inhibited by an L-arginine analogue, L- 
NMMA, (b) NO could react with the Fe-S groups forming an iron-nitrosyl complex causing the 
inactivation and degradation of the Fe-S prosthetic groups of aconitase and complex I and complex II of 
the mitochondrial electron transport chain, (c) Alternatively, NO can react with 02“* to form ONOO" 
(peroxynitrite) which decays rapidly once protonated to form the highly reactive HO*.
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temperature in phosphate buffer saline containing NO (Liew, et al., 1990). The 
importance of NO, in vivo, is demonstrated by the finding that disease in CBA mice 
infected with L. major is exacerbated when L-NMMA is injected into the lesions resulting 
in a IQLfold increase in the number of parasites that can be extracted from the lesions 
(Liew, et al., 1990).
1.3.2. Inflammation
Increasing evidence indicates that NO may play a part in acute and chronic 
inflammation. Treatment with L-NMMA reduces the degree of inflammation in rats 
(lalenti, et a l, 1992) with acute inflammation or adjuvant arthritis (lalenti, et a l, 1993) 
whereas L-arginine enhances it. Immune complex-induced vascular injury in rat lung and 
dermal vasculature can be attenuated by inhibitors of NOS (Mulligan, e ta l,  1991). In the 
carrageenin-induced acute inflammation model, the NO inhibitor (L-NMMA) can reduce 
inflammation and down-regulate inflammatory cytokines in mice (lanaro, et a l 1994). 
Furthermore, the colonic synthesis of NO is increased in patients with ulcerative colitis 
(Middleton, et a l, 1993), and inhibitors of NOS ameliorate experimentally induced 
chronic ileitis (Miller, et a l, 1993). In addition, nitrite concentrations in plasma and 
synovial fluid are increased in patients with rheumatoid arthritis and osteoarthritis (Farrell, 
et a l, 1992). The origin of NO in the inflammatory process is unclear.
1.3.3. Autoimmunitv
NO may play a part of role in tissue damage, for it may be cytostatic or cytotoxic 
not only for invading microorganisms but also for the cells that produce it and for 
neighboring cells (Moncada,. 1992). In MRL-lpr/lpr mutant mice, NOS inhibitors prevent 
anti-DNA immune complex glomerulonephritis and reduce the intensity of inflammatory 
arthritis (Weinberg, et a l,  1994) (MRL-lpr/lpr is a lupus mouse strain which was 
developed by Murphy and Roths in 1979). Pancreatic p cells have a rather limited 
capacity for free radical scavenging and are thus highly sensitive to NO cytotoxicity. In 
pharmacologically induced models of insulin-dependent diabetes mellitus and nonobese
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diabetic mice, progressive insulitis, dysfunction and eventual killing of pancreatic p cells
correlate with the induction of iNOS and are, in some reports, abrogated by NOS
the investigation of the consequences of altered gene expression and of the ablation of
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inhibitors (Lukic, et al, 1991; Kolb, et a l, 1991; Green, et a l, 1994).
The iNOS is multi-functional. It is essential for the defence against pathogens
,
such as parasites. However, it can also cause tissue injury inducing inflammation and 
autoimmune diseases. So far, all the evidence of iNOS functions have been demonstrated 
by using NOS inhibitors, which are analogues of L-arginine and are not NOS isoform 
specific. To further define the role of iNOS, iNOS gene targeted mice will be very useful.
Part II. Gene Targeting in Mice
1.4 .  New strategies in animal genetics
It is no accident that our understanding of the development and function of 
animals of different species parallels the power of methods available for their genetic 
analysis. Progress has been slower even in the best-understood experimental mammal, 
the mouse, because genetic analysis is limited by longer generation times, which 
determine the rate at which information can be accumulated from breeding studies, and 
larger size, which places a practical limit on the numbers of animals which can be studied. 
However, a revolution is now sweeping through mammalian genetics. Whereas until 
recently the discovery of desired mutations was a matter of chance, techniques developed 
in the mouse and currently being extended to other species make it possible to tailor
animals with predetermined alterations in their genome. These techniques have already
had an enormous impact on fundamental biology in such areas as the understanding of
developmental regulation of gene expression, the study of cell lineage relationships and
chosen tissues. In biomedicine they offer the opportunities to produce animal models of 
human disease and to engineer animals that produce proteins of therapeutic importance, 
and a basis for the development of techniques for human somatic gene therapy.
The first of these techniques of germline manipulation to be developed was the 
production of transgenic mice, i.e. mice carrying additional exogenous DNA sequences in 
their germline. This can be achieved either by retroviral infection of early embryos or by 
microinjection of DNA into one pronucleus of the fertilized egg (Jaenisch, 1988). Over 
the last decade these techniques have made enormous contributions to our understanding. 
They do, however, have several limitations. They are restricted to the addition, rather than 
removal or replacement, of DNA sequences, so that it is not possible to produce recessive 
mutations systematically in a chosen gene. The inserted DNA sequence integrates 
randomly rather than at the homologous chromosomal site, and frequently in the form of 
several tandemly arranged copies, and it is not possible to characterise the integration site 
or determine the copy number prior to producing and animal. Also, the method can only 
be applied to the study of dominant lethal changes if a way can be found to make them 
conditional. These limitations do not apply to a more recently developed technique for 
germline manipulation using embryonal stem cells (ES cells; alternatively designated as 
embryonic stem cells, embryo-derived stem cells or EK cells).
ES cell lines, which are established from peri - i mplantati on mouse blastocysts 
(Evans and Kaufman, 1981; Martin, 1981), have many properties in common with 
embryonal carcinoma (EC) lines established from the malignant stem cells of 
teratocarcinomas, including the ability to colonize the somatic tissues of chimaeric mice 
following injection into host blastocysts. However, they have two important advantages 
over EC cells. First, lines with normal karyotypes can be readily obtained, and second, 
karyotypically normal ES cells are frequently capable of colonizing the germ-cell lineage 
of chimaeras (Bradley, et a i, 1984). This raises the possibility of using the techniques of 
somatic cell genetics to isolate ES cells carrying any of a variety of genetic modifications, 
and then introducing these modifications into the germ line. This approach is particularly 
well suited to the introduction of recessive mutations, and has become especially powerful 
as a consequence of recent developments in cell genetics. Homologous recombination 
between native chromosomal gene and exogenous DNA can be used in culture to modify 
specifically the target locus (Smithies, et al., 1985). The recombination is a low frequency
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event, so that selective techniques or powerful rapid screening methods are required to 
allow isolation of the recombinant cells, but these can be made independent of the 
properties of the gene and thus of broad application. This approach, known as gene 
targeting or targeted mutagenesis, has now been applied to the introduction of substantial 
number of recessive mutations into the mouse germline. The more detail will be 
introduced below.
1 .5 .  Gene targeting in mice
1.5.1. Homologous recombination
When a fragment of genomic DNA is introduced into a mammalian cell it can 
locate and recombine with the endogenous homologous sequences. The first experimental 
evidence for the occurrence of gene homologous recombination was made using a 
fibroblast cell line with a selectable artificial locus (Lin, et al., 1985) and was 
subsequently demonstrated to occur at the endogenous p-globin gene in erythroleukaemia 
cells (Smithies, et al., 1985).
In gene targeting technology, homologous recombination has been exploited to 
alter endogenous genes by replacing them with homologous recombination constructs in 
which the gene sequences have been interrupted. Despite the success of the gene targeting 
technology, mechanisms and cellular enzymes involved in homologous recombination are 
largely unknown. The understanding of this machinery will be of great value in 
improving the efficiency of gene targeting. It has been speculated that the physiological 
role of homologous recombination in cells is the repair of chromosomal breaks and the 
generation of genetic diversity that propels the evolution of organisms.
In mammalian cells, exogenous DNA is generally integrated randomly at non­
specific sites; only rare occasions does the introduced DNA recombine with and replace 
its chromosomal homologous through homologous recombination. The ratio of 
homologous recombination events to random integration in mammalian cells is about 1 to 
1000 (Thomas, et al. 1987). The frequency of homologous recombination seems to be
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affected by the extent of homology between the homologous recombination construct and 
endogenous chromosomal DNA (Thomas, et al 1987), but not by the length of the non- 
homologous region transferred to the target locus (Mansour, et al. 1990). Neither the 
copy number of the target DNA sequences present in the genome (Zheng, et al. 1990) nor 
the number of exogenous DNA molecules introduced into recipient cells (Thomas, 1986) 
has a significant effect on the frequency of gene targeting. An early study showed that the 
frequency of homologous recombination is similar in transcriptionally active and in silent 
P-globin loci (Thomas, et al. 1986). However, transcription activity of the targeted gene 
has recently been shown to enhance homologous recombination in mammalian cells 
(Nickiloff, et al. 1990 ).
1.5.2. Design of a gene targeting construct
There are two types of homologous recombination constructs: firstly, the insertion 
type that creates a partial duplication of the gene, and secondly, the replacement type that 
involves two reciprocal recombination events (Fig. 1.3). They result in the replacement of 
the endogenous DNA with an homologous recombination construct, and have both been 
used to inactivate the targeted gene. The replacement gene construct is commonly used in 
gene targeting in mice. Considerations for a gene replacement construct should not only 
be for generating a mutation to disrupt the gene functions, but also for increase 
homologous recombination efficiency for convenient screening.
Generating the mutation. The deletion should be made as large as possible in the 
replacement construct to ensure complete disruption of the genes function. If the gene is 
small, delete the entire gene, or if the gene is large, the important 5' exons. A replacement 
construct has been designed that causes a deletion of up to 17kb of genomic DNA without 
a significant decrease in frequency of homologous recombination. (Mombaerts, et al. 
1991). Disruption of the start coding sequence by a positive selection marker will in most 
instances ablate a genes function.
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Figl.3. Gene inactivation by homologous recombination with (a) an 
insertion construct and (b) a replacement construct, X is the site of 
homologous recombination.
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Efficient homologous recombination. Using isogenic DNA (the genomic DNA 
from same mouse strain as the ES cells) to construct the targeting vector can result in 20- 
fold more efficient gene targeting (Riele, et al. 1992). The length of the homologous 
sequences will affect the targeting frequency. For most vectors the length of homology 
should be in the range of 5-8 kilobases.
Considerations for the recombination event in screening. If Southern blotting is 
used, the restriction enzyme sites in the construct should give size changes of 
hybridisation bands with external or internal probes after gene recombination. The 
restriction enzymes used for screening should be efficient in digesting the chromosomal 
DNA. If PCR is to be used to screen for gene replacement events, the positive selection 
marker should be cloned so that one of homology arms is 0.5-2.Okb.
1.5.3. Embrvonic stem (ESI cells
Characteristics of ES cells. Murine ES cells are permanent cell lines, established 
from blastocysts of the inner cell mass of pre-implantation mouse embryos. The 
pluripotent state of ES cells can be maintained in vitro by culturing in medium 
supplemented with a soluble factor called leukaemia inhibitory factor (LIP) or 
differentiation inhibiting activity (DIA), or by co-culturing with mitotically inactivated 
feeder cells, such as embryonic fibroblasts or the fibroblastic STO cell line. When ES 
cells are returned to the embryonic environment, they can resume normal development 
and contribute to all cell lineages including the germ line of the resulting chimeric mice. 
Genetic manipulations that require massive screenings can, therefore, be performed in ES 
cells in vitro and mutant mice generated from the genetically modified ES cells. Isolation 
from the genetically modified ES cell lines was first demonstrated in 1981 (Evans, and 
Kaufman, 1981; Martin, et al., 1981). Now a number of ES cell lines have been shown 
to be capable of germ line transmission. All the existing ES cell lines are derived from 
male embryos because the XY karyotype appears to be more stable in culture than the XX 
karyotype . Thus, most of the germ line transmission chimeric mice are males.
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Targeted ES cell clones. Using stringent culture conditions, ES cells can maintain 
their embryonic developmental potential even after many passages. Gene targeting 
construct can be introduced by either microinjection or electroporation. Electroporation is 
the fastest and easiest way to introduce the targeting vector with the selection marker. 
Following the drug resistant selection and genetic mutation screening, cloned ES cells 
with the targeted mutation are isolated and injected back into mouse blastocysts to 
generate chimeric mice. In theory, this genetic manipulation technique will allow us to 
generate any type of mutation in any cloned gene. The mutations that can be created 
include null mutations, point mutations, deletions of specific functional domains, 
exchanges of functional domains from related genes, and gain of function mutations in 
which exogenous cDNA sequences are inserted adjacent to endogenous regulatory 
sequences.
1.5.4. Screening for a genetic mutation in ES cells
The selection markers. Although different strategies are used to design the gene 
targeting construct, a positive selection marker is always used in the targeting vector. 
After the introduction of the targeting vector into the ES cells, all the neomycin analogue 
(G418)-resistant cells will have the targeting vector in the chromosomal DNA, either by 
random integration or by homologous recombination. To ensure expression of the marker 
gene in cells, a strong promoter such as the phosphoglycerate kinase I promoter, the RNA 
polymerase II promoter, the thymidine kinase promoter from herpes simplex virus or the 
murine p-actin promoter, is used to drive the expression of the marker gene. Negative 
selection can also be used to further enrich for cells with homologous recombination 
events. Toxic genes are used in negative selection by placing them in the gene targeting 
construct flanking the homologous region, so that the toxic genes will remain in the 
construct if DNA is randomly integrated into chromosomal DNA, but will be excluded if 
the constmct has undergone homologous recombination with the endogenous gene.
Screening for the homologous targeting events. One of the most important aspects 
of any gene targeting experiment is to confirm that the desired genetic change has
38
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occurred. This change can be detected with polymerase chain reaction (PCR) or Southern 
blot. PCR is by far the most sensitive and fastest screening method which can be used for 
a large number of screenings, but the homologous recombination events normally need to 
be confirmed by Southern blot. An external probe is normally used in Southern blot 
sereenings, which is generated the flanking sequence of the homologous region in the
targeted gene sequences. The external probe does not hybridise with the construct
■
sequence, so that random integration is not detected with external probe. To avoid the 
insertion event, both external probes from 5' and 3' ends are normally used to confirm the 
gene replacement event.
1.5.5. Introducing mutated genes into mice
An ES cell line with targeted mutation, normally in one chromosome, is returned
to the embryonic environment by injection into a host blastocyst. They can contribute to 
many kinds of tissues in the resulting chimeras. Some of the chimeras, when mature, will 
produce sperm derived from the ES cells. These are so called germ-line transmission 
animals which can be easily detected by the offspring coat colour. Because the ES cells 
are derived from a mouse homozygous for the agouti coat colour (129/Sv) allele and the 
recipient blastocyst is derived from a black coat colour mouse (C57 B16). The fur of the 
resulting chimeras has patches of both colours because the mouse contains cells of both 
genotypes. Breeding of the chimeras to an MPI albino mouse yields some chinchilla coat 
colour mice, indicating that the ES cells contributed to the formation of the genn line, but
.
not for the black coat colour progeny. By mating the germ-line transmission chimeras 
with wild type mice, heterozygous offspring can be generated carrying the mutation in 
one of two copies of the gene in every cell. These heterozygous mice should be healthy in 
most instances, because their second, undamaged copy of the gene will still be 
functioning properly. To identify heterozygous and wild-type mice in this stage, the DNA 
from tail tipping is examined by Southern blot or PCR. Matings between heterozygous 
siblings would result in one in four of the offspring having two defective copies of the 
gene homozygous. Gene mutation analysis by Southern blot will find two targeted
a
I
mutation presence in the homozygous mice. The transcription of this targeted gene can be 
detected by Northern blot or by reverse transcription PCR, and the protein translation can 
be detected by Western blot. Biological phenotypes can now be investigated. The
1 . 6 .  Summary and rational of the project
procedure for constructing gene mutant mice is summarised in Fig 1.4.
NO is a crucial mediator of a variety of biological functions, including vascular 
relaxation, platelet aggregation, neurotransmission, tumoricidal and microbicidal activity 
and immunopathology. There are at least three isoform of NOS, the enzyme generating
NO from L-arginine and molecular oxygen. ncNOS and ecNOS are calcium-dependent 
and expressed constitutively in many mammalian cell types. The cytokine inducible iNOS 
is calcium independent and is inducible in many mammalian cells. Once induced, iNOS 
catalyses the production of large amounts of NO which can be cytotoxic. iNOS is 
therefore important in the hosts' defence against infectious pathogens and tumours, but 
excessive production of NO generated by iNOS can also lead to a range of important 
immunopathologies.
The role of iNOS has so far been demonstrated using L-arginine analogues which 
competitively inhibit all isoforms of NOS. This has led to considerable discrepancy in 
result interpretation. To define the role of iNOS more precisely, this project was designed 
to construct iNOS-deficient mice by gene targeting, a technique which has proved 
invaluable in defining many biological systems.
5 :
The specific aims of this project are as follows:
1. Cloning and mapping of the murine iNOS cDNA from J774 cells and 
genomic DNA from 129s/v ES cells.
2. Constructing iNOS-deficient mice.
3. Investigating the phenotype of iNOS-deficient mice.
Experimental design and results obtained, together with their implications will be 
presented and discussed in the following chapters.
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Fig 1.4.. Major steps of the procedures involved in the generation of gene targeting 
mutant mice.
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Chapter 2
Materials and Methods
^ ' 1
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2.1. Lambda phage
A colony of XL 1-Bine (E.coli ) was added to 10ml LB supplemented with 0.2% 
maltose and lOmM MgSO^. The culture was grown overnight with vigorous shaking at 
37®C, and was centrifuged at 2000xg for lOmin. The pellet was resuspended in 10ml of 
lOmM MgS0 4 . Cells were stored on ice prior to use.
Dilute X ZAPII J774 cytokine induced macrophage cDNA library (which was 
made by Dr. Ian Charles, Wellcome Research Laboratory, Beckenham, U.K.) to 10  ^ , 
102, 103, 104, iq5, in SM solution (lOOmM NaCl, lOmM MgSO^, 50mM Tris.HCi 
pH7.5, 0.01% gelatine). 20p,l diluted phage was mixed with 200pl treated XLl-Blue 
cells respectively and incubated at 37®C for 20min. Melt 0.7% top agarose was kept in a 
5 5 0 C water bath for use. 3ml of warm top agarose was mixed well with infected bacteria 
and poured on the plates. After the top agarose has set, the plates were incubated in the 
3 7 0 c  incubator for overnight (12-18 hours).
2 . 2 .  Library screening
Plates with a good density of plaques (about 200-400 plaques/plate) were selected 
and placed in the fridge for 2 hours to make the top agarose hard. Plaques were transfered 
to nitrocellulose (NC) filters (A and B as duplicate). The phage DNA were denatured in 
the denaturing solution (1.5M NaCl, 0.5N NaOH) for 5 min. Neutralisation was carried 
with the neutralisation solution (1.5M NaCl, 0.5M Tris-Cl pH 8.0) for 7 min. Finally the 
filters were rinsed in the rinse solution (0.2M Tris-Cl pH7.5, 2xSSC) for 30 seconds. 
The filters were dried at room temperature and baked at 8CPC for 2 hours. 20xSSC is 3M 
NaCl, 0.3M Sodium Citrate pH 7.5.
The filters were placed in a plastic box, 100ml pre-hybridisation solution (6xSSC, 
3.3%SDS, 20mM NaH2P0 4 ,1 OO r^g/ml tRNA) was added and shaken at 65°C for 2 
hours for pre-hybridisation. The radioactived probe was added to the pre-hybridisation 
solution and hybridisation carried out overnight.
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2 . 4 .  Lambda phage DNA purification
The filters were washed at room temperature twice with 2xSSC, 0.1%SDS for 15 
minutes each. They were then washed with 0.5xSSC, 0.1% SDS at 65°C for 30 minutes.
(if the background was high, the filters were washed again with O.IXSSC, 0.1 SDS).
The filters were exposed to X-omat AR auto radiography film (Kodak) for 4-8 hours at 
-70°C in cassettes fitted with Kronex intensifying screens (Kodak). The film was 
developed with an automatic X-ray developer (Kodak).
2 . 3 .  Double stranded DNA probe labelling
..i:
. Double stranded DMAs were labelled with using a commercially
available random priming kit (Gibco BRL). The DNA was heated to 96®C for 10 minutes 
in a 1.5ml screw tube and chilled on ice. Samples of 25ng-50ng DNA was mixed with 
2 pi each of 0.5mM dCTP, 0.5mM dGTP and 0.5mM dTTP, 15pl of concentrated 
random primer reaction buffer, 5 pi (50pCi) of a^^P-dATP (Amersham), lul Klenow 
DNA polymerase (Exonuclase-free, 2units/pl) and distilled H2O was added to 50pl. The 
reaction was allowed to proceed at 37°C for at least 30 minutes and stopped by the 
addition of 50pl of TE buffer (lOmM Tris.HCi, pH7.5, ImM EDTA).
The Nick Column (Pharmacia) was pre-equilibrated with 2ml of TE buffer and 
lOOpl reaction mixture loaded onto the top of the gel bed and allowed to enter into the gel 
completely. 400ul of TE buffer was supplied to the column . The DNA probe was eluted 
with another 500ul of TE buffer and collected in a 1.5ml screw cap tube. Un-incorporated 
a^2p_(j^pp was retained in the column which was discarded. The labelled cDNA was 
denatured by heating at 96°C for 10 min and chilled on ice prior to addition into the pre­
hybridisation solution.
The genomic libraries of two strains of mice, B6  and 129/sv, have been made in a 
X EMBL phage vector and a X DASH vector respectively, so the lambda DNA containing 
the iNOS-specific inserts has to be purified in order to carry out the gene mapping and 
subcloning experiments.
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A total of IQio plating cells were infected with a single plaque in a 10 ml L-broth 
culture and left shaking at 37®C overnight. This culture was used as phage stock for 
making DNA.
1ml of phage stock was used to inoculate 200ml of L-broth containing lOmM 
MgS0 4  and left overnight at 37°C with vigorous shaking. The culture was checked for 
lysis the next day and was completed by the addition of 1ml of chloroform with vigorous 
shaking at 37°C for a further 10 minutes. The bacterial debris was then pelleted out at 
15,000xg for 10 minutes at 4°C. The supernatant was treated with RNase and DNase 
(each at a final concentration of lOmg/ml) at 37®C for 1 hr. The phage were precipitated 
by adding an equal volume of 20% PEG, 2M NaCl on ice for 1-2 hr and pelleted by 
centrifugation for 30mins at SOOOxg, 4°C. The pellet was drained well, resuspended in 
10ml of SM buffer (O.IM NaCl, 50mM MgS0 4 , 50mM TrisHCl pH 7.5, 0.01% 
gelatine) and extracted 3-4 times with chloroform to remove traces of PEG. Phage DNA 
was then extracted by adding 0.5ml 0.5M EDTA (pH 8.0), 1ml 5M NaCl and mixing 
with TE-buffered phenol followed by centrifugation for lOmins. The phenol extraction 
was repeated and the aqueous phase was re-extracted twice with chloroform. Phage DNA 
was precipitated with 2.5 volumes of ethanol, washed in 70% ethanol and air dried before 
resuspending in TE.
2 . 5 .  Excision of pBluescript from the lambda ZAPII vector
The mouse J774 macrophage cDNA library was constructed in the lambda ZAPII 
vector (Stratagene) by Dr. Ian Charles, (Department of Cell Biology, Wellcome Research 
Laboratories). The mRNA was isolated from J774 macrophages activated with lOng/ml 
LPS and lOOunits/ml IFN-y. When the host strain XLl-Blue was co-infected with the 
recombinant lambda ZAPII and helper phage, the phagemid was formed by excision of 
the pBluescript. The XLl-Blue was subsequently infected with this phagemid and grown 
in ampicilin medium, the pBluescript plasmid was amplified. In this way, cloned cDNA 
were effectively subcloned in plasmid directly from lambda phage.
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An XLl"Blue colony was inoculated in 60ml LB containing 0.2% maltose, lOmM 
M gS04 at 37°C overnight with vigorous shaking. At the end of the growth, a 10ml 
sample of the bacterial culture was pipetted into a 50ml tube and centrifuged at 4000xg for 
20min at 4^C. The bacterial pellet was resuspended in 10ml chilled lOmM MgSO^and 
kept on ice for use as competent cells. For a typical excision experiment, 200pl the above 
XLl-Blue competent cells, 200pl X ZAPII phages carrying the iNOS cDNA fragment 
and lp.1 of R408 helper phage were mixed in a 50ml tube and incubated at 37®C for 15 
minutes. 5ml of 2xYT media (lOg NaCl, lOg Yeast Extract and 16g Bactarial tryptone in 
1 litre dH2 0 ) was added and incubated at 37°C for 3 hours with vigorous shaking. The 
culture was heated at 70“C for 20 minutes and centrifuged at 8000xg for 5 minutes. The 
supernatant (containing phagemid) was decanted into a sterile tube. lOp.1 of phagemid and 
20p,l 1/100 2xYT diluted phagemid were mixed with 200p,l of the above XLl-Blue 
respectively and the mixture was incubated at 37°C for 15 minutes. 20jxl and lOOp.1 of the 
culture respectively were placed on the LB agar plates containing lOOpg/ml ampicillin. 
The plates were incubated at 37°C overnight.
2 . 6 .  DNA restriction enzymes digestion
In this study, a range of different buffer systems and restriction endonucleases 
(both from Boehringer Mannheim) were used to digest DNA into required fragments. 
Five different buffer (A, B, L, M, H) were supplied suitable for different restriction 
enzyme reactions (Table 2.1). All the restriction endonuclease digestion of double 
stranded DNA was carried out at 37°C. In general, for the cloned and purified DNA, up 
to l^ig of DNA was digested in the presence of 10-20 units of the enzymes in a volume of 
20-50p,l for 1-4 hours. The purified genomic DNA from ES cells and mouse tails were 
digested with more enzyme (60 units) and longer time (overnight) in lOOjil total volume.
2 . 7 .  Dephosphorylation reaction of DNA fragment ends
To avoid the self ligation of plasmid vector, the digested plasmid vector was 
normally dephosphorylated on the 5' phosphate residue by the addition of lp.1 (lunit/fxl)
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calf intestine alkaline phosphatase (Boehringer Mannheim). This was included in the 
restriction endonuclease digest reaction. As an alternative, the phosphatase buffer and 
phosphatase were used directly after the enzyme digestion step.
2 . 8 .  Agarose gel electrophoresis
Nucleic acids were routinely analysed by electrophoresis through agarose gels. In 
this study, gels were made at a range of concentrations from 0 .6 % to 1 .0 % depending on 
the size of the fragment and amount of DNA. For plasmid subcloned DNA digestion and 
analysis of PCR products, the 0.8%-1.0% agarose gels were used. However, for X 
phage DNA and genomic DNA digestion, 0.6%-0.7% agarose gels were used. Gels were 
made by dissolving the required amount of dry agarose powder(Gibco BRL) in 1 X TBE 
buffer or 0.5 X TBE buffer from lOxTBE stock buffer [200mM TrisHCl pH 8.0, 
900mM Boric acid, 25mM Ethylenediamine tetra-acetic acid (EDTA)] by boiling or in 
microwave oven. The melted gels were allowed to cool to 45°C and ethidium bromide 
(Sigma) was added to the final concentration of lOng/ml. Gels were cast in tanks with 
combs where they were allowed to set. After setting space, gels were submerged in TBE 
buffer and the well-forming combs were removed. The samples of the DNA and Ikb 
DNA ladder (Gibco BRL) were mixed with loading buffer (6 xloading buffer: 0.25% 
bromophenol blue, 150mM Tris.HCi pH8.0, lOmM EDTA, 40% sucrose) and loaded 
into the relevant wells on the gel. Gels were electrophoresed at a constant current of 
lOmA/cm gel-length or a constant voltage of l-5V/cm of gel-length until the bromophenol 
blue had migrated the required distance. Gels were then analysed under ultra-violet light 
and photographed if necessary.
2 . 9 .  Purification of DNA fragments from agarose gels
DNA bands were visualised with Ethidium Bromide by short-wave UV 
illumination. The relevant band was excised with a clean scalpel and placed in a 
Eppendorf tube. 1.5ml of Freeze-Squeeze buffer (25mM Tris, 0.3M Sodium Acetate, 
ImM EDTA pH7.0) was added and the sample kept in the dark at room temperature for
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15 minutes. The buffer was then discarded and the Eppendorf tube with the agarose 
inside was placed in dry ice for 10 minutes. The frozen gel slice was then rapidly 
transferred to a Spin X centrifuge filter tube (Costar) and centrifuged for 15 minutes at 
15,000xg. The agarose in the filter was discarded and the DNA solution was extracted 
with phenol/chloroform and chloroform before precipitation with ethanol.
2 . 1 0 .  DNA ligation
Following restriction digestion and purification, the DNA fragments with 
compatible sticky ends or those with blunt ends were ligated using DNA ligase isolated 
from the bacteriophage T4 (Gibco BRL). Approximately equimolar amounts (usually 
about 0.1-0.5p,g DNA ) of the fragments to be ligated and the appropriately digested and 
purified plasmid DNA were mixed and incubated with l\i\ of T4 ligase (1 unit/p-1) in 
ligation buffer (50mM Tris HCL pH 7.6, lOmM MgCl2 Jm M  ATP,lmM DTT and 5% 
w/v polyethylene glycol 8000) (Gibco BRL) in a total volume of 10(xl. Control ligations, 
replacing the cDNA fragments with water but retaining the plasmid DNA were also set up 
to calculate the degree of self ligation. Ligations were allowed to proceed either overnight 
at 16^C or at room temperature for 4 hours. Following ligation, the cDNA was not further 
purified prior to its use in bacterial transformation.
2 . 1 1 .  Transformation of bacterial strains
Two methods were utilised to promote the uptake of plasmids into either 
subcloning efficiency DH5a (Gibco BRL) or XL-1 blue (Stratagene) E, coli host cells. 
Initially, a heat shock method was used whereby 5\i\ (approximately 500ng of DNA) of 
the ligation mixture was mixed with 50ul competent bacterial cells and incubated on ice 
for 30 minutes in an Eppendorf tube. Positive control transformations were set up 
replacing the experimental sample with Ing of the plasmid pUC19 to assess the efficiency 
of plasmid uptake. The DNA-cell mixture was then incubated at 37®C for 22 seconds 
before a second incubation on ice for 5 minutes. 1ml of 2xYT broth (1.6% w/v bacterial 
tryptone, 1% w/v yeast extract and 0.5% w/v NaCl, pH 7.5) was added to the
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transformation mix and this was then incubated at 37^0 with vigorous shaking for 1
hour. The bacteria were pelleted by centrifugation at 15,000xg for 10 seconds at room
temperature and resuspended in lOOpl of 2xYT broth. Bacteria were then plated onto
85mm petri dishes (Sterilin) containing L-agar (1% w/v bacterial tryptone, 0.5% w/v ^
yeast extract, 1% w/v NaCl and 1.5% w/v agar, pH7.5 and 100p,g/ml Ampicillin). Plates
were incubated overnight at 37®C and examined for the growth of colonies of transformed 
■
bacteria the following day. The bacteria earring the plasmid with ampicillin resistant gene 
will survivie in the L-agar containing ampicillin.
IIn some experiments, and with certain plasmids, the L-agar contained ImM 
isopropyl thio-p-D-galactoside (IPTG) (Gibco BRL) and 50[xg/ml 5-bromo-4-chIoro-3- 
indolyl-p-D galactoside (X-gal) (Gibco BRL). This allowed for the selection of bacteria 
carrying recombinant plasmids by the appearance of white colonies. Those not carrying 
an inserted DNA fragment retained the ability to metabolise galactose analogues and 
therefore produced blue colonies due to the presence of IPTG and X-gal.
An electroporation method for the high efficiency introduction of recombinant 
plasmids into XL-1 blue host cells was used in some experiments, a fresh XLl-blue 
overnight culture was inoculated into 500 ml of L broth at 1:100 dilution and the cells are 
grown with vigorous shaking to an OD600 of approximately 0.4. The cells were 
harvested by cooling on ice for 15 minutes and pelleted at 4000xg for 15 minutes at 4°C. 
The cells were resuspended in 250ml of ice cold distilled H2O and re-pelleted twice. This 
centrifugation step was repeated sequentially with 50ml of 10% glycerol. Finally the cells 
were resuspended in a final volume of 2ml of 10% glycerol. The cell concentration should 
be approximately 3 x 10^ ® cells/ml and samples were stored frozen at -80°C in 40pl 
aliquots.
An aliquot of the cells prepared for electroporation was thawed on ice. Plasmid 
DNA or ligation reaction in 1-3 (xl of distilled H2 O was added and the mixture of cells and 
DNA was then transferred to a cold 0.2 cm electi'oporation cuvette and placed on ice. The 
Gene Puiser apparatus (Biorad) was set to 25fxF and 2.5 KV, the pulse controller was set
1
1:1
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chamber and 1 ml of 2xYT was added to the cells. The cells were allowed to recover by
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to 200W . The cells were pulsed once and the cuvette is immediately removed from the
growing at 37”C for 1 hour before plating on ampicillin plates.
2 , 1 2 .  Isolation of plasmid DNA
Plasmid DNA was isolated using a modification of a previously published method 
(Jones and Schofield, 1990). Colonies carrying a putative plasmid of interest was 
inoculated into 3ml of 2xYT broth containing lOOpg/ml ampicillin (Sigma) and grown for 
18 hours at 37°C with vigorous shaking. At the end of the growth period, 2ml of the 
bacterial culture were pipetted into an eppendorf tube and centrifuged at 15,000xg for 2  
minutes at room temperature. The pellet was resuspended in 200p,l of GTE buffer (50mM 
glucose, 25mM tris.HCl pH8.0, ImM EDTA) and to this was added 400pl of freshly 
prepared 0.2N NaOH containing 1% SDS. This was then incubated on ice for 5 minutes 
before the addition of 300pl of 3M potassium acetate pH 4.8. After a further 5 minutes 
incubation on ice, samples were centrifuged at 15,000xg for 1 0  minutes at room 
temperature. The supernatant was transferred to a fresh eppendorf tube, mixed with 
900ul of ethanol and centrifuged immediately at 15,000xg for 5 minutes at room
temperature. The pellet was washed once in 1ml of 75% ethanol by centrifugation at 
15,000xg for 2 minutes at room temperature. The pellet was allowed to dry at room 
temperature and then resuspended in 50ul of TE buffer containing 10 unites of RNase 
(DNase free). Following incubation for 5 minutes at 37“C, the samples were stored 
frozen at -20°C. This so-called 'mini-prep' generated DNA that was suitable for both 
restriction enzyme digestion and DNA sequencing.
For the ES cell electroporation, large scale production of high purity plasmid DNA 
was performed using a commercially available 'maxi-prep, kit (QIAGEN). A 50ml culture 
of bacteria containing the required plasmid was grown overnight to stationary phase in 
2xYT broth containing ampicillin (50pig/ml). Cells were pelleted by centrifugation at 
8000xg for 20 minutes at 4°C. The pellet was resuspended in 10ml of Tris-HCl pH 8.0
containing lOmM EDTA and 100f.ig/ml RNase A and mixed immediately with 10ml of
0.2N NaOH containing 1% SDS and incubated at room temperature for 5 minute. 10ml of 
ice-cold 3M potassium acetate pH 4.8 was then added and the incubation continued for a 
further 20 minutes on ice, mixing by inversion every 5 minutes. The lysate was 
transferred equally to two 20ml centrifuge tubes, centrifuged at 15,000rpm for 30 minutes 
at 4°C and the pellet discarded. The supernatant was pooled and passed through a 
'QIAGEN-500' column, pre-equilibrated with 10ml of QBT buffer (0.75M NaCl, 50mM 
3-[N morpholino] propane sulphonic acid (MOPS), 15% ethanol, 0.15% triton X- 
100,pH 7.0). The eluate was discarded and the column washed with 60ml of QC buffer 
(IM NaCL, 50mM MOPS, 15% ethanol, pH 7.0). The bound plasmid was eluted from 
the column with 15ml of QF buffer (1.25M NaCl, 50mM Tri.HCl, 15% enthanol, pH 
8.5), mixed with 10.5ml of isopropanol at room temperature and centrifuged at 
15,000rpm for 60 minutes at 4°C. Following careful aspiration of the supernatant, the 
pellet was washed once in 10ml of ice-cold 70% ethanol by centrifugation at 15,000rpm 
for 10 minutes at 4°C. The pellet was air dried for 5-10 minutes at room temperature, 
resuspended in 200p,l of distilled water and stored at -20“C. The concentration of DNA in 
the sample was estimated by absorbency at 260nm in a quartz cuvette.
2 . 1 3 .  DNA sequencing
Nucleotide sequence of cDNA clones in a variety of plasmid vectors was analysed 
by a modification of the di-deoxy chain termination method (Sangar et al. 1983) using a 
commercially available kit (United States Biochemicals ) from which all reagents were 
taken unless otherwise stated. lOng of plasmid DNA was denatured in the presence of 
0.2N NaOH for 15 minutes at 37^C in a total volume of lOjxl. lOpg of a 17 base pair (bp) 
oligonucleotide sequencing primer (either supplied in the kit or made in house by Mr. H. 
Spence, Department of Cell Biology, Wellcome Research laboratories), in a volume of 
lp.1, is mixed with the denatured DNA and allowed to anneal for 5 minutes at room 
temperature. The DNA-primer complexes were then precipitated by the addition of 3fxl of 
3M KO Ac pH 4.8 and 75|xl of 100% ethanol and incubated at -7CPC for 20 minutes, 
followed by centrifugation at 15,000xg for 15 minutes at room temperature. The ethanol
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was aspirated and the pellet washed once in lOOpl of 75% ethanol followed by 
centrifugation at 15,000xg for 5 minutes at room temperature. Following aspiration of the 
ethanol, the pellet was air-dried at room temperature for 1 0  minutes and resuspended in
I8 ul of distilled water. To this was added 2\i\ of 5x concentrated reaction buffer (0.2M 
Tirs HCl, pH 7.5, O.IM MgCl2  and 0.25M NaCl), l|xl of O.IM DTT, 2pl of labelling 
mix (7.5p,M dCTP, 7.5p.M dGTP and 7.5ixM dTTP) 2pl of 'Sequenase' recombinant 
phage T7 DNA polymerase (13 units/fxl) (pre-diluted 1 in 8  in lOmM Tris HCl, pH7.5, 
5mM DTT and 0.5mg/ml BSA), 0.5p,l (5p,Ci) of a-^^S dATP (specific activity: 
lOOOCi/mmol, Amersham). The reaction was allowed to proceed at room temperature for 
5 minutes and aliquoted into 4 Eppendorf tubes (3.3pl/tube). To each tube was added 
2.5p,I of one of the following termination mixes: l).ddA; 80pM dATP, dCTP dGTP, 
8 pM dideoxy ATP (ddATP). 2).ddC: as above but with ddCTP replacing ddATP. 
3).ddG: as above but with ddGTP. 4).ddT: as above but with ddTTP. Each tube was 
incubated at 37®C for 5 minutes prior to the addition into each tube of 4pl of stop solution 
(95% formamide 20mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol). All 
tubes were heated to 80°C for 5 minutes and stored on ice prior to electrophoresis. In 
some experiments, termination mixes contained 80pM 7-deaza-nucleotides to help to 
resolve regions of sequence with strong secondary structures or high G/C contents.
Electrophoresis was performed through 6 % PAGE gels containing 8 M urea 
(Gibco BRL) in 1 x TBE buffer. Samples were run at 50W constant power for 2-3 hours 
at room temperature or until the bromophenol blue marker reached the bottom of the gel. 
In some experiments, the xylene cyanol marker was run to the end of the gel to allow 
reading of the sequence further from the primer binding site. After electrophoresis, gels 
were fixed in 20% methanol, 10% glacial acetic acid for 30 minutes, transferred to 3MM 
filter paper and dried under vacuum at 80°C for 1-2 hours. Dried gels were exposed to X- 
omat AR autoradiography film (Kodak) for at least 18 hours at -70®C in cassettes 
(Kodak).
Total oligo Mr in Da
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2.14. Introduction of a synthetic oligonucleotide pair into a plasmid i
vector
Synthetic oligonucleotides were suppiled freeze-dried and reconstituted by the 
addition of 500pl of distilled water. A 1 in 100 diltution was prepared in distilled water 
and the U.V. absorbance measured at 260nm against a water blank. For single stranded 
DNA, an absorbance of l=approximately 37pg/ml. The values obtained were converted 
to molarity on the assumption that the average molecular weight of 1 DNA base is equal to 
324 Dd using the formula:
'Î?
X oligo concentration in t»g/ul x 10-6 = moles oligo/jrl
Phosphate residues were added to the 5’ end of each oligonucleotide in a reaction volume
of 40pl containing 50mM Tris HCl, pH 7.5, 5mM DTT, lOmM MgCl2 , ImM ribosomal 
ATP and 10 units of phage T4 polynucleotide kinase (lOunits/pl) (Gibco BRL). This 
reaction was allowed to proceed for 30 minutes at 37®C after which time complementary 
pairs of oligonucleotides were pooled and 2pl of 5M NaCl added. The pooled 
oligonucleotide mix was then heated to l(X)oC for 5 minutes and allowed to cool slowly to 
room temperature over a period of 2-3 hours. Oligonucleotides were designed with the 
required restriction sites 'pre-cut' to obviate the neccessity of restriction digestion and 
were not further purified prior to ligation with plasmid vector. Ipg ofa  range of dilutions 
of annealed oligonucleotides (from neat to 1 in 1000) were ligated with lOOng of 
appropriately digested plasmid as descrided previously for plasmid vector ligations and 
transformed into competent E. coli. Recombinant plasmid from transformed bacteria was 
analysed by restriction digestion and nucleotide sequence analysis.
I
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2 .1 5 .  Southern blot analysis of Lambda phage DNA and genomic DNA
Analysis of genomic and lambda DNA by restriction enzyme digestion, gel 
electrophoresis and radioactively-labelled probe hybridisation were performed in this 
study. About lOpg of genomic DNA or Ipg of Lambda DNA was digested with the 
appropriate restriction enzymes and subjected to agarose gel electrophoresis as previously 
described. Following electrophoresis, the gel was photographed alongside a fluorescent 
ruler under U.V. light and then incubated in 10 volumes of denaturing buffer ( 0.5M 
NaOH, 1.5M NaCl) with gentle shaking for 45 minutes at room temperature. The 
denaturing solution was decanted and the gel washed briefly in several changes of 
distilled water prior to the addition of 10 volumes of neutralisation buffer (IM Tris HCl, 
pH 7.4, 1.5M NaCl). The gel was incubated in neutralisation solution for 30 minutes 
with gentle shaking after which time the buffer was decanted and washed again with 
several changes of distilled water. 4 sheets of Whatman 3MM filter paper and 1 sheet of 
nylon filter were cut to the same size as the gel. The nylon filter was soaked in 2 x SSC 
(0.3M NaCl, 42mM Sodium citrate, pH 7.2) for 20 minutes. The longer filter paper was 
cut and placed on a perspex block, (approximately the same size as the gel), in a bath 
containing 1 litre of transfer buffer (20xSSC) with the 'tails' in contact with the buffer. 
The gel was removed from the neutralisation buffer and placed 'well-side' down on the 
filter papers and surrounded with 'parafilm' (Sigma) to prevent transfer buffer flowing 
around the outside of the gel. The nylon filter was placed on the top of the gel and the 
remaining 2 sheets of filter paper (which were wetted in 2xSSC) were placed on top of 
the nylon filter. The entire blot assembly was rolled lightly with a glass rod to remove air 
bubbles from between the layers which would othervise interfere with the transfer and 
another 2 sheets of filter papers placed on top. A stack of paper towels approximately the 
same size as the gel is placed on top of the blot assembly followed by a glass plate and a 
500g weight. Capillary transfer is allowed to proceed overnight at room temperature. The 
next day, the gel was removed and discarded. The nylon filter was washed briefly with 
2xSSC and dried between 2 sheets of 3MM filter paper at room temperature. The DNA 
was then baked onto the nylon at 120°C for about 20 minutes.
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For blots using restriction endonuclease digested X DNA, the nylon filter was 
prehybridised in the prehybridisation buffer [6 xSSC, 0.02M NaH2 P0 4  , lOOpg/ml
denatured salmon sperm DNA (Sigma) and 0.1% SDS] for 2-3 hours. At the end of the 
prehybridisation, a specific cx-^^P dATP labelled DNA probe, prepared as described 
previously, was added directly to the solution and incubation was allowed to proceed at 
65®C for a further 18 hours in a hybidisation oven (Scot-lab). Following the 
hybridisation, the blot was washed with 2xSSC, 0.1% SDS twice and 0.2 x SSC, 0.1%
SDS for another two times at 65®C.
For the genomic DNA blots, the Church-Gilbert buffer (7% SDS, 40mM 
NaH2 P0 4 , ImM EDTA 100p,g/ml ssDNA) was used. The blots were washed with wash
,
buffer 1 (5% SDS , 40mM NaH2P0 4 , ImM EDTA) at 65®C for 30 minute and wash 
buffer 2 (0.1% SDS, 40mM NaH2P0 4 , ImM EDTA) at 65®C for another 30 minutes 
twice. The blots were removed from the last wash, dried between 2 sheets of 3MM paper 
for 30 minutes at room temperature and exposed to X-ray film for times between 1-3 days 
depending on the signal.
2 .1 6 .  Isolation of total cellular RNA
Total RNA was isolated using 'RNAzoUM a commercially available 
guanidinium thiocyanate-phenol method (Biogenesis Ltd.). Distilled water, treated for 18 
hours with 0.2% diethyl pyrocabonate (DEPC; Sigma) and then autoclaved , was used to 
make all solutions not supplied with the kit. Cells growing as suspension cultures were 
pelleted by centrifugation at 2000xg and lysed in 400p.1 of RNAzoRMb . Effective lysis 
was facilitated by vigorous pipetting. Following disruption, lysates were vortexed for 15 
seconds in the presence of 40fxl chloroform. Samples were then centrifuged at 15,000xg 
for 15 minutes at 4®C and the colourless 200[xl upper phase (containing exclusively RNA) 
was removed to a fresh Eppendorf tube. RNA was precipitated by the addition 200jxl of 
isopropanol and pelleted by centrifugation at 15,000xg for 15 minutes at 4®C. The RNA 
pellet was washed once in 75% ethanol by centrifugation at 15,000xg for 5 minutes
before being resuspended in 20p,l TE buffer. The concentration of RNA in samples was 
estimated using ultra-violet spectroscopy. A 1 in 500 dilution of the sample was made in 
DEPC-treated distilled water and the absorbance at 260nm and 280nm was measured 
using quartz cuvettes and a water blank. An absorbance of 1.0 at 260nm was equal to 
approximately 40pg/ml RNA. The RNA was judged to be free from protein contaminants 
if the absorbance ratio 260mm/280mm was greater than 1.8 .
2 . 1 7 .  Isolation of polyadenylated messenger RNA (polyA+mRNA)
Isolation of poly A+ mRNA is based upon oligo (dT) cellulose affinity binding 
and performed using a commercially available 'Fast-Track' kit (Invitrogen). Up to 1 x 
1 0^ cells from either suspension or monolayer culture were pelleted by centrifugation at 
2000xg for 5 minutes at room temperature and washed twice in PBS by repeat 
centrifugation. Cells were transferred to Eppendorf tubes, centrifuged at 2000xg for 5 
minutes at room temperature and the pellet lysed in 1ml of lysis buffer (PBS containing 
0.1% SDS and RNase degrader as supplied with the kit) at 45®C for 20 minutes. 5M 
sodium chloride (NaCl) was added to a final concentration of 0.3 IM and the DNA that 
precipitated was sheared by passage several times through a 21 guage needle. One oligo 
(dT) cellulose tablet was added to the lysate and allowed to disperse. The mixture was 
then incubated with gentle shaking for 20 minutes at room temperature. The oligo (dT) 
cellulose was then sequentially washed by centrifugation at 5000xg 3 times each in 200p,l 
of high and then low salt buffer to remove contaminating cell debris, proteins, DNA, 
tRNA and rRNA. Poly A+ mRNA were eluted from the cellulose in 200^1 of buffer 
without salt and precipitated by the addition of 10p,l of glycogen carrier, 30p,I of 2M 
sodium acetate and 600pl of ice cold ethanol. The precipitate was collected by 
centrifugation at 13,000xg for 20 minutes at 4®C, washed once with 1ml of 75% ethanol, 
re-centrifuged, air-dried and resuspended in 20pl of DEPC treated distilled water. RNA 
yields were quantified by ultra-violet spectroscopy as previously described.
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2 . 1 8 .  Reverse transcribed polymerase chain reaction (RT-PCR)
- Reverse transcribed polymerase chain reaction (RT-PCR) was performed using a 
commercially available 'GeneAmp RNA-PCR' kit (Perkin Elmer Cetus). Reverse 
transcription of RNA to cDNA was performed on 50ng of poly A+ mRNA or 2pg of total 
RNA , isolated as described above. RNA was mixed with the following reagents supplied 
with the kit: 4(tl 25mM MgCl2 , 2|tl each of lOmM dATP, dCTP, dGTP, dTTP, 1^1 
RNase inhibitor (20units/p.l), l[xl recombinant reverse transcriptase from moloney murine 
leukaemia virus (50 units/p.1), l^il 50p,M random sequence hexanucleotides and 2pl of 
DEPC treated distilled water. This mix was incubated at room temperature for 10 minutes,
42®C for 15 minutes, 99®C for 5 minutes and finally chilled on ice. This protocol allowed
.
annealing of the random hexamers and conversion of the RNA sequence (via reverse 
transcriptase) into cDNA. In some experiments, a mixture of random hexamers and oligo 
(dT) (lp.1 of a 50pM stock) were used to prime poly A+ mRNA for reverse transcription.
Following reverse transcription, 4pl 25mM MgCl2 , and 8 |xl lOx concentrated 
PCR buffer were added to each sample. Target sequence-specific oligonucleotide primer 
pairs were then added to a final concentration of 20ng/ml (usually 5|xl of a 40pg/ml 
solution) and distilled water added to take the final volume to 99.5p,l. 0.5p,l (5units/fxl) of 
recombinant DNA polymerase from Thermus aquaticus ('Amplitaq') was added and the
mixture is overlayed with lOOfxl of mineral oil (Sigma). The entire reaction mixture was
subjected to thermal cycling under the following standard conditions: Dénaturation at
95®C for 1 minutes, primer binding at 56®C for 2 minutes and sequence extension at 
72®C for 3 minutes for 35 cycles.
PCR was also performed on cDNA and genomic DNA samples without the 
requirement for reverse transcription. In these experiments, O.lng -50ng of target cDNA 
or genomic DNA were mixed with 4pl 25mM MgCl2 , lOp.1 lOx concentrated PCR 
buffer, 2pl each of lOmM dATP, dCTP, dGTP, dTTP, 20ng/ml each specific primer, 
0.5p,l (5units/p,l) Am/?//taq and distilled water to 100|xl. Cycling was as described 
previously.
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52 . 1 9 .  ES cell culture
■:,3;
CGR8  ES cells were cultured in gelatine-coated tissue culture flasks in Glasgow 
modified Eagle's medium (GMEM) supplemented with 10% fetal calf serum (PCS), Ix 
non-essential amino acids, O.lmM p-mercaptoethanol, ImM sodium pyruvate and
lOOU/ml DIA/LIF
2 . 2 2 ,  Neomycin (G418) resistance colony selection
24 hours after transfection, cells were selected in medium containing 175mg/ml of
2 .2 0 .  Purification and linearisation of the Gene targeting vector
. In this study, the gene targeting vector was purified using a QIAGEN kit and
linearised with the restriction enzymes Sad. The linearised vector was repurifed either by
■
phenol/chloroform extraction or by elution from an agarose gel to remove the plasmid 
vector. 150pg purifed DNA was used for electroporation.
2 . 2 1 .  Electroporation of ES cells
The CGR8  ES cells were trypsinised to generate single cells, washed with cold 
PBS twice and counted. Cell concentration was adjusted to 10  ^in 0.8ml PBS. The cells 
were mixed with ISOpg purified and linearised DNA and transfered to an electroporation 
cuvette. An electric pulse (800V, 3pF and time constant) was applied. The cells were 
transfered into 200ml of ES cell medium containing LIF (Leukaemia Inhibition Factor). 
2 0 ml of the cell suspension was aliquoted into ten 1 0 0 mm gelatinised dishes and the 
medium containing LIF changed 24 hours after transfection.
I
G418 for about 10 days. Single G418 resistant colonies were picked into 24-microwell 
plates coated with gelatin. Cells were expanded and each clone was split into 2 plates.
Half of these cells was frozen in situ, while the other half was used for Southern blot 
analysis.
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2 . 2 3 .  Preparation of low temperature agarose ES cell plugs
box at -20®C overnight before transferred to the -7CPC freezer.
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Confluent cells grown in the duplicate 24-microwell plates were trypsinised, 
transferred into Eppendorf tubes and washed once with PBS, cell pellets were 
resuspended in 50p,l of PBS and 70pl of 1% low melting agarose (prewarmed at 60*^ C) 
and left to set as a plug on ice. Agarose plugs were then transferred into Eppendorf tubes 
and were incubated at 55°C overnight in NDS buffer (1% lauroyl Sarcosine, 0.5M EDTA 
pH 9.5) in the presence of Img/ml of proteinase K.
2 . 2 4 .  Restriction digestion of DNA in plugs
Plugs were washed twice with TE containing O.lmM PMSF followed by one 
washing with distilled water for at least 1 hour for each wash. After washing, plugs were 
equilitrated with Ix restriction buffer for 1 hr at 4 C. Restriction digests were performed 
in 60pl of Ix restriction buffer containing 40 units of restriction endonuclease enzyme at
37®C for 4 hrs or overnight. Half or one third of a plug was used for each digest and the
:
rest of the plugs were kept at 4®C in TE buffer.
2 . 2 5 .  Screening G418 resistant clonies
Homologous recombinant ES clones were identified by Southern hybridisation of 
Hind III and ÊcoR I respectively digested DNA prepared from agarose plugs with both 5' 
and 3' external probes.
2 . 2 6 .  Freezing, storage, and thawing of ES cell line
Short-term freezing of ES cell clones in 24 well plates: The cells were grown to 
confluency in 24 well gelatine coated plates in the GMEM medium containing LIF. The 
supernatant was aspirated and 250|xl/well of freshly made freezing medium (20% FCS,
10% DMSO in ES cell culture medium) was added. The plates were place in a pre-cooled
Long-term freezing of ES cell stocks: The ES cells were trypsinised from 80mm
2 .2 7 .  Blastocyst injection and the production of chimeras
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flasks (Costar) to make a single cell suspension and pelleted by centrifugation at 450xg 
for 5 minutes. Cells were resuspend in 1.5 ml ES cell medium (the cells density was 
about 5xl0^/ml) and 0.5ml aliquots of the cell suspension were placed into freezing vials 
on ice. Another 0.5ml of 2x freezing medium was added to each tube. The samples were 
mixed gently and transfered to a pre-cooled rack in the -70®C freezer overnight before 
transferring to liquid nitrogen.
Thawing of ES lines frozen on 24 well plates: The plate containing the cells was 
removed from the -70®C freezer and 1 ml of pre-warmed GMEM medium was added. 
The plate was incubated on a pre-warmed metal block in an incubator for 5-10 minutes, 
The medium was aspirated and the freshly pre-warmed GMEM medium was added 
immediately. For the cells frozen in the vials, the tube was taken out of the liquid nitrogen 
and transfered to a 37®C water bath immediately. The thawed cell suspension was 
transfered to 10ml GMEM medium and the cells were pelleted by centrifugation and 
resuspended in 10ml GMEM medium containing LIF. The cells were cultured for 24 
hours and the old medium is removed. The fresh GMEM medium was added to get rid of 
the DMSO.
Recombinant ES cell clones were microinjected into C57BL/6 blastocysts. 
Blastocysts were usually cultured for 1-3 hours in PB-1 medium before injection to allow 
the biastocoel cavities to fully expand. ES cells were trypsinised and washed once with 
injection medium. 15-20 ES cells were injected into each blastocyst and 6-10 injected 
blastocysts were transferred to the uterine horn of a pseudopregnant F1(CBA/J x 
C57BL/6J) recipient mouse. Chimeric pups were identified by chimeric coat colour.
Because the ES cells were derived from a mouse homozygous for the agouti coat colour
.
(129/sv) allele and the recipient blastocyst was derived from black coat colour mouse 
(C57 Black6 ). The fur of the resulting chimeras has patches of both colours because the
mouse contains cells of both genotypes.
2 . 2 8 .  Germline transmission and the generation of mice heterozygous
Chimeric males were initially test bred with MFl females and germline 
transmission of the mutant iNOS allele was detected by Southern blot analysis of tail 
DNA from FI offspring with grey coat colour. Germline transmitting male chimeras were 
bred to MFl and 129 females to obtain the mutation on hybrid or a pure in-bred 
background.
2 . 2 9 .  DNA isolation from mice tails and yolk sac
The tails of neonates, the tail tip of 3 week-old mice and the yolk sac of 10.5, 
13.5, 15.5 g.d. (gestation days) onwards embryos were placed in 0.5ml of lysis buffer 
(lOmM Tris pHS.O, 50mM EDTA, lOOmM NaCl, 0.5% SDS and 500p.g/ml proteinase 
K), Digestion was done at 55®C overnight. The next day, the lysate was extracted once 
with phenol and chloroform, DNA was ethanol precipitated, washed with 70% ethanol, 
and resuspended in 100ml of TE at 4®C overnight. 10p,l of DNA was used for the 
restriction enzyme digestion.
2 . 30 .  Elicitation and culture of peritoneal macrophages
Mice were injected intraperitoneally with 2ml of sterile 3% Brewer's thioglycollate 
(Difco) in PBS. 3-4 days later the mice were killed by cervical dislocation while under 
terminal anaesthesia and swabbed with ethanol. 5ml of DMEM was injected into the 
peritoneal cavity through a 28 gauge needle attached to a 5ml syringe. The carcass was 
gently massaged and the fluid withdrawn. The number of macrophages in the exudate 
was estimated using a Neubauer haemocytometer by differential microscopy. Following 
centrifugation at 15(X)xg, the cell pellet was resuspended at a cell density of 1x10^ 
macrophages/ml in DMEM medium supplemented with 10% FBS, 2mM L-glutamine, 
lOOIU/ml penicillin and lOOpg/ml streptomycin (Gibco BRL).
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2 ,3 2 .  Northern blot
2 . 3 3 .  iNOS Western blotting
2 . 3 1 .  Griess reaction for NO% measurement
Nitrite concentration in the culture supernatants was determined by a microplate 
assay described by Ding et al. (Ding, et al., 1988). Briefly, 50p,l samples were havested 
from the conditioned medium and treated with an equal volume of Griess reagent (1% 
sulfanilamide / 0.1% napthylethylene diamine dihydrochloride / 2.5% H3PO4) at room 
temperature for 10 minutes. The absorbance at 570nm was monitored with a microplate 
reader. Nitrite concentration was determined by using sodium nitrite as a standard. The 
results were displyed as: NO2PM.
I
I
The RNA was separated by electrophoresis in 1.5% agarose with 7.5% 
formaldehyde. Briefly, 3g of agarose was melted in 175ml DEPC treated distilled water 
and was cooled to 60®C before adding 10ml of 20xMOPS buffer (400mM MOPS,
122mM NaOAc, 20mM EDTA pH 7.0 in DEPC water), 15ml formaldehyde, mixed and 
poured into the gel tray. Gels were run in IxMOPS buffer at lOOV. RNA markers for 
gels were purchased from Promega. I
,1
Agarose-formaldehyde gels were rinsed twice in distilled water after
..
electrophoresis. The RNA was then transferred onto a nylon membrane (Pharmacia) by 
capillary blot as for DNA. After transfer, membranes were rinsed in 2xSSC, air dried and 
oven baked at 120®C for 20 minutes.
I
Stimulated cells were washed with ice cold TBS (Tris-buffered saline) before 
being lysed in buffer containing 25mM Tris.Cl PH7.4, 150mM NaCl, 1% NP-40, ImM 
vanadate, ImM EDTA, 2mM EGTA, lOmM NaF, ImM D.T.T., 50pg/ml Leupeptin, 
50pg/ml Aprotinin, and 50|xg/ml PMSF. Clarified lysates (30pg) were resolved on 7.5% 
SDS-polyacrylamide (Bio-Rad) gels and transferred to nitrocellulose membrane (Bio- 
Rad).
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(ECL: Amersham Life Science).
2 . 3 4 .  Growth and maintenance of Leishmania major
For immunoblotting with iNOS antibody, membranes were blocked in Tris- 
buffered saline containing 0.1% Tween-20, and 2% BSA and incubated sequentially with 
monoclonal anti-iNOS (Affiniti) and horseradish peroxidase-conjugated donkey anti- 
mouse IgG (SAPU), and visualised protein bands by using enhanced chemiluminescence
Leishmania major strain MRHO/SU/59P, also know as LV39, was used in this
study. The isolate was maintained in the laboratory by continuous passage in BALB/c 
mice to maintain virulence. Non-ulcerated lesions of mice, infected four to five weeks 
previously in the right, hind footpad with 1x10^ parasites in 50(xl Phosphate Buffered Ï
Saline(PBS), were removed and cut into small pieces in a petri dish(90mm) containing 
10ml PBS. Parasites were further dispersed by forcing the suspension through a 5ml 
syringe placed against the bottom of the petri dish. The suspension was filtered into a 
univeral using Monofilament Nylon Filter Cloth (NITEX) (Cadisch and Sons Ltd,
'
London, U.K.) to remove remaining debris and washed twice by centrifugation at 1300g
5
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for 10 minutes at 4°C. After the final wash the pellet was resuspended in 5mls of 
Complete Schneiders Medium (CSDM), consisting of Schneiders Drosophila Medium 
(SDM) (Gibico) containing 20% FCS (Gibco) and 2.5% L-glutamine (Gibco). The 
parasites were then incubated for 3-4 days at 28®C in 25cm3 tissue culture flasks 
(Corning, New York, U.S.A.) to transform amastigotes. For storage, parasites were then 
centrifuged at 1300g and resuspended in 2ml of CSDM containing 10% Dimethyl
'■•I
Sulfoxide (DMSO) (Sigma Chemical Co., Dorset, U.K.). A lOfxl aliquot of this
'
suspension was removed, diluted 1:100 in PBS containing 2.5% Formalin (Sigma 
Chemical Co.) and the number of parasites counted using an Improved Neubauer 
Haemacytometer (Merck Ltd, Dorset, U.K.). Parasites were diluted to 2xl0’^ /ml in
":R
CSDM containing 10% DMSO, aliquoted into 1ml freezer vials and kept at -70®C 
overnight before storage in liquid nitrogen.
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For growing L. major in vitro a vial was thawed from liquid nitrogen at room 
temperature and the contents cultured for three days in 5ml CSDM at 28®C. Parasites are
then passaged in vitro in CSDM in a 80cm^ tissue culture flask (Coming) and culturing 
at 28®C. Parasites were not maintained in vitro for longer than 4 passages for fear of loss 
of virulence.
2 . 35 .  Leishmania major infection
Parasites at passage 1-4, but preferably using passage 1-3 at day 6 - 8  (in the log 
phase) were centrifuged and washed twice with PBS. The parasites were diluted to 2 x 
10'7/ml with PBS and the mice were challenged in one of the hind footpads with 1 x 
10^/50|al L, major promastigotes. The lesions that developed were measured as 'footpad 
thickness increase' with a direct reading using a Vernier calliper gauge (GMH-309-t, 
gallenkamp, London).
2 . 3 6 .  Preparation of parasite antigens
L.major was grown in vitro as described above and harvested at 7-10 days after
passage. In experiments where live parasites were used, these were merely washed twice 
with sterile PBS, counted and resuspended at the required concentration in Complete 
RPMI consisting of RPMI 1640 containing 10% heat-inativated FCS, 2mM L-glutamine, 
lOOU/ml penicillin (Gibco), lOOpg/ml streptomycin (Gibco) and SOpM 2- 
mercaptoethanol (Sigma), formalin-fixed parasites were obtained by fixing parasites 
(2xl0^/ml) in 0.5% formaldehyde (Sigma) in PBS for 5 minutes at room temperature 
followed by three washes in sterile PBS before resuspending in complete RPMI. Soluble 
Antigen was prepared by freezing and thawing parasites (2xl0^/ml in PBS) 5 times 
followed by centrifugation at 13,800g for lOminutes. The resulting supernatant was
filtered using a 0.45pM filter (Millipore S.A., Molsheim, France) and diluted in Complete 
■
RPMI. Parasites were also sonicated (20kHz, 1 minute) using a Branson Sonifier 250 
(Branson Ultrasonics Corporation, Danbury, CT, USA.) in PBS (2xl0^/ml) and 
resuspended in Complete RPMI.
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2 . 3 7 .  Parasite quantitation in footpads
'j
The number of parasites present in infected footpads was quantified using one of 
two methods as previously described. At the time points after infection, footpads were 
removed from mice by cutting the foot above the ankle. Footpads were cut into small 
pieces in CSDM in a petri dish (90mm) and then filtered through NITEX. The resulting 
suspension was serially diluted in triplicate in 96 well tissue culture plates containing 
complete CSDM. Plates were incubated at 289C and examined every two days for parasite 
growth. Data were presented as the logio of the reciprocal of the last dilution showing 
parasite growth.
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2 . 3 8 .  ELISA for IL-4 and IFN^v
In this study, the levels of cytokines in culture supernatants were measured by 
ELISA, using paired antibodies from PharMingen ( A,M,S, Biotechnology Ltd., Witey, 
Oxon, UK ). The cytokine levels (pg/ml) were determined according to the standard 
curve. Briefly, anti-cytokine monoclonal antibodies were diluted to 2p,g/ml for IL-4 
ELISA and to lOtig/ml for IFN-y in the coating buffer (O.IM NaHCOg, pH 8.2 ) and 
50jxl/well applied to enhanced protein binding ELISA plates (Dynatech Immunlon 4)
overnight at 4®C. The plates were washed twice with PBS/TWeen 20 (0.05%) as washing 
buffer, and blocked with lOOpl/well of 10% FCS in PBS for 1 hour at 37®C, then 
washed twice with the washing buffer. 50|xl of the supernatant from the cell culture and 
diluted cytokine were added to the plate at 37®C for 3 hours. After washing four times 
with washing buffer, 50p.l of biotinylated anti-cytokine detecting antibody (Ipg/ml) was 
added and incubated for 1-2 hours at 37®C. The plates were washed six times with 
washing buffer before adding lOOpl of the extravidin-peroxidase (2|Lig/ml ) and incubated 
for 1 hour at 37®C. The plates were washed six times and the colour was developed by 
adding 100p,l/well of TMB substrate for 10-30 minutes. The OD was read at 630nm with 
a reference filter at 490nm.
2 . 3 9 .  Measurement of specific antibody responses
2 . 4 0 .  Antigen specific proliferation in vitro
1
Blood was harvested from the heart of L. major infected mice and serum obtained 
by centrifugation at 350xg. Soluble L. major antigen as above described was coated onto 
Immulon-4 96-well plates (Dynatech Laboratories Ltd., Billingshurst, West Sussex, 
U.K.) in a volume of 50p,l/well and incubated overnight at 4®C. Plates were washed 
twice using PBS containing 0.05% Tween-20 and blocked with 100p,l/well of 20% FCS
in PBS and incubated at 37®C for 1 hour. Plates were again washed twice using PBS/Tw, 
■
and serial dilutions of serum samples added to wells in a volume of 50^il, before plates 
were incubated for 2-3 hours at 37®C. Serum from infected mice and monoclonal 
antibody against gp63 (Dr. W.R. McMaster) were used as control serum against gp63.
Plates were washed 6 - 8  times in PBS/Tw and then conjugated antibodies added to detect
IgG, IgG2a or IgGl in a volume of lOOp.1 and incubated at 37®C for 2 hours. ELISA's 
detecting IgGl were washed a further 6 - 8  times and lOOul of Extravidin-Peroxidase 
(Sigma Chemical Co.) added at a concentration of 3pg/ml. All ELISA's were then
washed 8  times in PBS/Tw before developing using TMB Micro well Peroxidase 
Substrate (Kirkegaard and Perry Laboratories, Gaithersburg, Maryland, U.S.A.). The 
colour change on the plates was measured using a MR5000 Microplate reader (Dynatech) 
at 630nm.
Antigen was prepared as described above and diluted in Complete RPMI to the 
required concentration before adding lOOpl/well to 96-well tissue culture plates (Costar). 
Spleen and MLN cells were removed from mice and single cell suspensions obtained by 
gentle homogenisation using a 15ml glass homogeniser. Cells were filtered to remove 
debris using NITEX and washed 3 times in RPMI. Cells were resuspended in 2mls of 
Complete RPMI and again filtered before couting using an Improved Neubauer 
Haemacytometer under phase-contrast microscope. The cell concentration were adjusted
4xl0^/ml and lOOpl added to each well in quadruplicate cultures. Cells were cultured at
y
66 i
67
37®C in 5% CO2, pulsed with ^H-Thymidine (IpCi per well), harvested on an automatic 
cell harvester and radioactivity counted in a p-counter (LKB).
2 . 4 1 .  Carageenan inflammation mouse model
The mice were injeeted in the right hind footpad with 300p,g of lambda 
carrageenin (Sigma) in 50p,l PBS. The control left hind footpad was injected with 50|il 
PBS alone. Footpad swelling was measured with a dial calliper as footpad thickness 
increase (right footpad - left footpad ±SEM).
2 . 4 2 .  LPS mouse shock model
The mice were injected intraperitoneally with lOmg/kg or 12.5mg/kg of LPS in 
0.2ml PBS. The body weights were measured everyday up to 4 days after injection. The 
body weight loss was calculated for the individual mice.
2 .4 3 .  T-cell proliferation assays
Spleens were removed from mice and single cell suspensions made by gentle 
homogenisation. The cells were washed twice with PBS and resuspended at 2xlCF 
cells/ml in culture medium ( RPMI 1640, or DEMAM, GIBCO BRL) supplemented with 
10% FCS, 200jxm glutamine, lOOunit/ml penicillin, lOOpg/ml streptomycin and 50p,m 2- 
mercaptoenthanol. The cells were cultured in 96 well microtiter plates (Costar) at 2 x 10^
ç
cells/well. The indicated concentrations of Con A or the antigen or live promstigotes of 
L. major were added into the cell culture. The cultures were set up in triplicate and 
incubated for 3-5 days at 37®C in 5% CO2 , pulsed for 6  hours with a high specificity 
thymidine, harvested with an automatic cell-harvester (WALLAC Pharmacia) and 
radioactivity counted in a p-counter (LKB, Betaplate, Turku, Finland). The supernatants 
were harvested for cytokines assays from the parallel cultures or the same cultures before 
the ^H-thymidine was supplied.
■m
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2 .4 4 .  T-ceU phenotyping
Expression of functional T-cell markers CD4, CDS and CD3 were analysed by 
using antibodies to these markers. The antibodies used in analysis were: PE-conjugated 
rat anti-mouse CD4 (4p,I/test, Becton & Dickinson), FITC-conjugated or biotinylated rat 
anti-mouse CDS (4p,l/test, Becton & Dickinson), and the pan-T cell marker hamster anti­
mouse CD3 FITC-conjugated (Clone 145-211, 0.5p,g/test, Boehringer Mannheim, 
Germany). Mouse spleen cells were dual-labelled as follows: Spleen cells were washed 2 
times with ice-cold PBS containing 0.1% sodium azide. For each sample, cells were 
prepared in 3 separate tubes, about one million cells per tube. Cells in each of the 3 tubes 
were incubated for 30 minutes at 4®C, with 2 of the above antibody conjugates at different 
combinations: anti-CD4 (PE) + anti-CDS (FITC), anti-CD4 (PE) + anti-CD3 (FITC), 
anti-CDS (Biotin) + anti-CD3 (FITC). Cells labelled with antibodies of the third 
combination were further incubated with PE-conjugated avidin (Vector Laboratory). The 
cells were then washed twice with cold PBS and resuspended in 1ml of PBS containing 
0.5% BSA for FACS analysis.
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Table 2.1. Buffer composition used in restriction enzyme digests.
(All concentrations are mM and are final in the reaction mixture)
Component Buffer A Buffer B Buffer L Buffer M Buffer H
Tris acetate 33
Tris.HCl 10 10 10 10
Mg-acetate 10
MgCl2 5 10 10 10
K-acetate 6 6
NaCl 1 0 0 50 1 0 0
DTE» 1 1 1
DTT» 0.5 _ _
2-Me* 1
pHat37®C 7.9 8 .0 7.5 7.5 7.5
*DTE=Dithioeryhtritol. DTT=Dithiothreitol. 2-Me=2-mercaptoethanol
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Table 2.2. Restriction endonucleases used and their recognition sites
Restriction Endonuclease Buffer Recognition Sequence 
5 -GGGCC / C-3'Apal
5'-G / G(A/T)CC-3'Ava II
BamW I 5'-G / GATCC-3
BrIW 5'-A / GATCT-3
Cla\ 5’-AT / CGAT-3
5'~G / AATTC-3
EcoRV 5'-G / ATATC-3
EccAl I 5'-AGC / GCT-3
//iwd III 5'-A / AGCTT-3
jKpwI 5'GGTAC / C-3
Ao/I 5’-GC / GGCCGC-3
Pstl 5'-CTGCA / G-3
Pvul 5'-CGAT / CG-3
Rvm II 5'-CAG / CTG-3
5'-G / TCGAC-3'
M I 5'-G / TCGAC-3
Sma I 5'-CCC /GGG-3
Spe I 5'-A / CTAGT-3
X bal 5’-T / CTAGA-3
Xho I 5'-C / TCGAG-3
Chapter 3
Inducible Nitric Oxide Synthase cDNA Clone
I:
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3 . 1 ,  Introduction
72
The first step of a gene targeting experiment is typically cDNA cloning and 
sequencing in order to make a cDNA probe to screen the genomic library. This also gives 
an understanding of the gene structure, which is helpful for the gene targeting construct
f
design. A cDNA library was constructed in the vector X ZAPII (Stratagene) using mRNA 
isolated from J774 macrophages activated with lOng/ml LPS and lOOunits/ml IFN-y by 
Dr. Ian G. Charles (Cell Biology Department of The Wellcome Research Laboratories).
Six independent positive colonies were found in the screen with both 5' and 3' specific 
probes and were subcloned in pBluescript. After the restriction enzymes mapping and 
terminal sequencing, two overlapping clones were used to make a full-length J774 iNOS
1
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cDNA. Double strand sequence was generated by universal primer sequencing of a nested 
set of deletions of the cDNA. Additional sequence was generated using specific primers 
designed from the sequence of the nested set. Apart from a four base pair deletion in one 
of the cDNA clones, the whole sequence was virtually identical to the published RAW 
264.7 cell iNOS cDNA sequence (Lyons et aL, 1992). The detail is described below.
3 . 2 .  XPhage cDNA library Screening
XLl-Blue was infected with a high density (10^) of X phage from the J774 cDNA 
library and plated on to 100mm plastic disposable petri disks with LB medium. The phage 
were transferred to nylon membranes in duplicate. The hybridisation was performed after 
the phage DNA was denatured and fixed on the membranes. 5* and 3' specific probes 
were purified from an agarose gel and labelled with a-p^p] dATP by the random primer 
method. The 5'-probe was generated by PCR using sequences around the ATG start 
codon from the published iNOS sequence.
5'-GGAGAAGCTTGGATTTGGAGCAGAAGTGCAAAGT-3' (sense from bases -48 to 
14) (According to the published sequence of RAW 265.7 iNOS cDNA, Lyons et a l,
1992) and 5'-CACTGGATCCTGCCGATGCAGCGAGGGGCATTCC-3' (antisense 
from bases 565 to 599). The 3' probe was generated by PCR using sequences
3 , 3 .  cDNA subclones
2; 4; 5; 6 ; 7; 10 which are showed in Fig.3.1.
3 . 4 .  Sequencing of subclones.
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corresponding to the NADPH binding domains of the enzyme. 5'- 
CCAAGAATTCACCTACTTCCTGGACATTACGACCCC-3' (sense from bases 2456 to 
2492) and 5’-GAAAGGATCCAAGGGAGCAATGCCCGTACCAGGCCC-3' (antisense 
from bases 2922 to 2958). Following hybridisation, positive phage plaques were picked
in addition to negative plaques as controls and infected with the host cells (XLl-Blue)
again and plated at low density. The screening was done twice in the same way with the 
same probes. Three independent phage were obtained from the 5'-probe screening, while 
another three were isolated from the 3'-probe screening.
To avoid the long procedure of cDNA subcloning involving phage DNA isolation, 
the X ZAP II vector was used to construct the J774 library. The phage vector contains a 
plasmid (pBluescript) component. The two separate domains (Initiator and Terminator) 
within the lambda ZAP II vector arms are recognised in the host bacteria by trans-acting 
proteins from the helper phage which can be co-infected. pBluescript plasmids with 
cDNA insert can be recovered by infecting an F' E.coli strain with helper phage and
growing in the presence of ampicillin. In this study, six overlapping cDNAs were
subcloned in the Not I site of the pBluescript (pBSSK-phagemid). The sizes of iNOS 
cDNAs insert are 2.7kb; 3.3kb; 1.3kb; 1.9kb; 2.6kb; and 1.5kb respectively for Clones
The T7 and T3 oligonucleotide primers were used for all terminal sequencing of 
subclones. The sequences were compared and identified with the published iNOS cDNA 
sequence using the GCG computer programs. The cloning map of J774 iNOS cDNA is 
shown in Fig 3.1.
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Fig.3.1. Cloning map of J774 iNOS cDNAs. Positions of clones isolated from the 
J774 cDNA library are indicated as arrows. Solid arrows represent clones isolated 
using a 3' iNOS PCR probe while striped arrows represent those isolated using a 5' 
probe.
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3 . 5 .  Making a full-length murine iNOS cDNA clone
For the creation of the full-length J774 cDNA, clone 10 was digested with Avr II 
and Xbal I while clone 4 was digested with Avr II, Hind III and Pvu I . The additional 
digestion with Pvu I is necessary as the insert of clone 4 is 3.0kb which is quite close in 
size to the vector (2.9kb for pBSSKII+), This digest effectively cuts the vector in half.
Fragments of l.Okb and 3.0kb corresponding to iNOS cDNA were recovered from the
I-
gel, ligated and inserted into Xbal I and Hind III sites of pBSSKII+ vector to construct 
the full-length J774 iNOS cDNA (pFU7) (Fig.3.2).
3 . 6 .  Double strand cDNA Sequencing for the J774 INOS cDNA clone
7.5pg of pFLJ7 was digested with Kpn I (as the 3' over hang end) and Hind III 
(as the 5' overhang). The exonuclease, Exo III, is an external nuclease which will only 
degrade double stranded DNA from 5' overhang ends, so pFLJ7 was deleted from the 
hind III end of the iNOS cDNA. After the nested set of deletions was made, the blunt 
ends (which were generated by SI nuclease) were religated and the time course of 
differentially deleted cDNAs were tranformated into E.coli.. DNA from representative 
subclones from different time points were purified by alkaline SDS mini-prep for 
sequencing with the T3 primer. The sequences were checked with the published iNOS 
cDNA sequence. The list of deleted cDNA clones and location are shown in Table 3.1 and 
the map of sequences covered on the full-length cDNA is shown in Fig.3,3. 3387bp of 
J774 iNOS cDNA sequence was obtained. The sequences corresponding to positions 
1271-1823 and 3557-3727 were not obtained by the nested deletions. In order to 
complete the cDNA antisense sequence, three sequence oligonucleotide sequence primers 
(BB78, BB79, BB80) were made and were used to determine the rest of J774 iNOS 
cDNA sequence.
BB78: GTGGCCAACATGCTACT 
BB79: GACCTTTCGCATTAGCA 
BB80: TCCAGCTCAAGAGCCAG
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Fig 3.3. The map of J774 iNOS cDNA antisense sequencing. The solid lines represent 
obtained sequence with the cDNA nest-set deletion system. The small triangles show the 
position of the sequence specific oligonucleotides used as primers.
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Table 3.1, The list of deleted cDNA clones and locations
No. The file names The location of iNOS cDNA sequence
1 WEI17D.DNA -14-242
2 WEIIB.DNA 174-424
3 WEIIC.DNA 157-401
4 WEI13B.DNA 265-486
5 WEIK7.1DNA 3-256
6 WEIK13.3DNA 32-242
7 ■ WEIK5.5DNA -90-151
8 WEIK5.3DNA -14-191
9 WEIK7.11DNA 140-430
10 WEIK7.2DNA 94-339
11 WEIK7.2DNA 157-396
12 WEIK1L7DNA 248-384
13 WEIK5.7DNA 458-663
14 WEIK5.9DNA 538-816
15 WEI13A.DNA 623-833
16 WEI19B.DNA 833-1010
17 WEI17A.DNA 737-970
18 WEIK9.6DNA 822-1015
19 WEIK11.12DNA 1083-1271
2 0 WEIK9.12DNA 1823-2036
2 1 WEIK17.2DNA 1908-2141
2 2 WEI13B.DNA 1999-2238
23 WEI17C.DNA 2033-2255
24 WEIS12.1DNA 2124-2312
25 WEIK15.6DNA 2277-2442
26 WEIS2.1DNA 2380-2556
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27 WEIK15.7DNA 2317-2567
28 WEIK15.10DNA 2312-2522
29 WEIK11.5DNA 2542-2761
30 WEIK9.2DNA 2755-3017
31 WEIK13.12DNA 2573-2755
32 ■WEI18.3DNA 2755-2920
33 WEIK13.7DNA 2727-2897
34 WEI13.10DNA 2801-2988
35 WEIS18.6DNA 2920-3187
36 WEIK7.6DNA 2954-3204
37 WEI9C.DNA 2988-3261
38 WEIK9.10DNA 3068-3255
39 WEIS16.4DNA 3130-3295
40 WEIS16.7DNA 3073-3352
41 WEIK9.5DNA 3090-3267
42 WEI7A.DNA 3318-3569
43 WEIS12.2DNA 3346-3557
44 WEI9D.DNA 3727-3875
45 WEIS8.1DNA 3727-3875
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In order to generate the sense DNA strand of the J774 iNOS cDNA, 20 
sequencing oligo nucleotides were synthesised by Mr. Hugh Spence in the Cell Biology 
Department of the Wellcome Research Laboratories. The sequences of the 17 mers are;
BB125; TCAACTGCAAGAGAACG BB126:
BB127; CAGAGACAAGCCTACCC BB128:
BB129; AGATGCCCGATGGCACC BB130:
BB131; AAGACCGGGCTGTCACG BB132:
BB133: TTGCTACTGAGACAGGG BB134;
BB135; GTCCGAAGCAAACATCA BB136:
BB137: TGCTCACTCAGCCAAGC BB138:
BB139: CCCTGCTTTGTGCGAAG BB140;
BB141: GCTACCACATTGAAGAA BB142:
BB143; GTGGACTACTAAATCTC BB144:
GCAGCTCCTCACTGGGA
CATCGGCAGGATCCAGT
AGCTCGGGTTGAAGTGG
TGAACTATGTCCTATCT
CTCAACCACACCTTCAG
GTTCAGCTCACCTTCGA
CATGTGCCCGCTGCCTT
CAGGAAGAAATGCAGGA
TCTGACAGCCCAGAGTT
TTTGGGTGACCACCAGG
Complete nucleotide sequence analysis of the coding region found that a four base 
pair deletion, from position 2595-2598 (GCAG) had arisen in clone 4. This deletion 
disrupted the iNOS ORF (Open Reading Frame) such that a stop codon was placed just 
downstream from the deleted region resulting in premature termination of any protein 
translation. The oligonucleotide sequence primer (BB137: TGCTCACTCAGCCAAGC) 
was used to sequence the remaining 3' iNOS cDNA clones (clones 2 and 5). The four 
base pair deletion was not found in either of them and the resulting sequence was found to 
be exactly same with the published sequence. The full-length iNOS cDNA (with the 4bp 
deletion) was used initially to construct an E, coli expression vector, which not 
surprisingly failed to express iNOS. Theoretically, any recombinant protein being 
produced from this construct could only have had a maximum Mr of 115kDa. The 
theoretical proteins translated from the cDNA with and without deletion are showed in 
Fig.3.4. The 5' region of the detective iNOS cDNA was digested out of pBSSKlI+ with 
Not I and Stu 1 and replaced with a corresponding region of clone 7 to create a full-length 
iNOS cDNA without the deletion. Enzymatically active recombinant iNOS was obtained
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in a Baculovirus expression system (this study has done by Dr. David W. Moss, Cell 
Biology Department, Wellcom Research Laboratories, see attached paper). Apart from the 
four base pair deletion found in clone 4 mentioned above, the full-length J774 iNOS 
cDNA is 100% identical with the published RAW 264.7 sequence in the coding region 
(Lyons et al., 1992), Analysis of the 5' and 3' untranslated flanking regions of the 
isolated cDNA showed only one nucleotide substitution (T for C at position 3473). The 
map of iNOS and the whole J774 iNOS cDNA sequence are showed in Fig.3.5 and 
Fig.3.6.
3 . 7 .  Summary
The results described above detail the iNOS cDNA cloning and sequencing. A full-length 
iNOS cDNA was constructed using clones isolated from a library made from mRNA 
isolated from activated J774 macrophages. Double-strand cDNA sequence analysis 
showed that the J774 iNOS clone was virtually identical to that of the RAW 264.7 
macrophages iNOS cDNA sequence (Lyons, et al., 1992). Analysis of the 5' and 3' 
untranslated flanking regions of the isolated cDNA showed a single nucleotide 
substitution (T for C at position 3473). Ligation of a Not I fragment of pBlueScript 
J7iNOS containing the full-length cDNA for iNOS into the baculovirus transfer vector 
pVL1393 resulted in iNOS expression. The expression and enzyme kinetic studies for 
recombinant iNOS were performed by Dr. David W. Moss in the Cell Biology 
Department of the Wellcome Research Laboratories. This work has been published in the 
European Journal of Pharmacology 289(1995) 41-48.
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Fig 3.5. Schematic representation of the iNOS protein encoded by the J774 iNOS cDNA. 
The solid box represents the highly conserved region shared between all NOS isofonns. 
The striped boxes represent FMN and FAD binding domains. The shaded regions denote 
the NADPH binding domains.
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Fig.3.6. The sequence of J774 iNOS cDNA 4117 bp
1 GGGACACAGT GTCACTGGTT TGAAACTTCT CAGCCACCTT GGTGAAGGGA CTGAGCTGTT 
61 AGAGACACrr CTGAGGCrCCTCAOGCTTGG GTCTTGTTCA CTCCACGGAG TAGCCTAGTC 
121AACTGGAAGA GAACGGAGAA OGTTGGAnT GGAGCAGAAG TGCAAAGTCT CAGACATGGC 
181 ITGCCCCrGG AAGnrcrCTTCAAAGrCAA ATCCTAŒAA AGTOACCTGA AAGAGGAAAA 
241GGACATTAAC AACAAOGTGA AGAAAAOCCC TTGTGCTGTT CTCAGGCCAA CAATACAAGA 
301 TGACXrrTAAG AGTCACCAAA ATGGCTCCOC GCAGCTCCTC ACTGGGACAG CACAGAATGT 
361TCCAGAATCC CTGGACAAGC TGCATGTGAC ATCGACCCGT CCACAGTATG TGAGGATCAA 
421 AAACTGGGGCAGTGGAGAGATnTGCATGA CACTCITCACCACAAGGCCA CATCGGATTT 
481CACITGCAAG TCCAAGTCTT GCTTGGGGTC CATCATGAAC CŒAAGAGTT TGAŒAGAGG 
541ACOCAGAGAC AAGCCTACCC CTCTGGAGGA GCTCCTGCCT CATGOCATTG AGTTCATCAA 
601CCAGTATTAT GGCTCCnTA AAGAGGCAAA AATAGAGGAA CATCTGGCCA GGCTGGAAGC 
661TGTAACAAAG GAAATAGAAA CA ACAGGAAC CTACCAGCTC ACTCTGGATG AGCTCATCTT 
721TGCCACCAAG ATGGCCTGGA GGAATGCCOC TCGCTGCATC GGCAGGATCC AGTGGTOCAA 
781CCTGCAGGTC TTTGACGCrC GGAACTGTAG CACAGCACAG GAAATGTTTC AGCACATCTG 
841CAGACACATA CTTTATGCCA CCAACAATGG CAACATCAGGTCGGCCATCA CTGTGTTCCC 
901CCAGCGGAGT GAOGGCAAAC ATGACITCAG GCTCTGGAAT TCACAGCTCA TCCGGTACGC 
961TGGCTACCAG ATGŒCGATG GCACCATCAG AGGGGATGCT GCCAOCITGG AGTTCACCCA 
1021 GTTGTGCATC GACCTAGGCT GGAAGCCCCG CTATGGCCGC TTTGATGTGC TGCCTCTGGT 
1081 CTTGCAAGCT GATGGTCAAG ATCCAGAGGT CnTGAAATC CCTCCTGATC TTGTGTTGGA 
1141 GGTGACCATG GAGCATCŒA AGTACGAGTG GTTCCAGGAG CTCGGGTTGA AGTGGTATGC 
1201ACTGCCTGOC GTGGCCAACA TGCTACTGGA GGTGGGTGGC CTCGAATTCC CAGCCTGCCC 
1261 CrrCAATGGT TGGTACATGG GCACGGAGAT TGAAGTTCGA GACTTCTGTG ACACACAGCG 
1321CTACAACATC CTGGAGGAAG TGGGOCGAAG GATGGGCCTG GAGACCCACA CACTGGCCTC 
1381CCTCTGGAAA GACCGGGCTG TCACGGAGAT CAATGTGGCT GTGCTCCATA GTTTCCAGAA 
1441 GCAGAATGTGACCATCATGG ACCACCACAC AGCCTCAGAGTCCTTCATGA AGCACATGCA 
1501GAATGAGTAC CGGGCCCGTG GAGGCTGCOC GGCAGACTGG ATTTGGCTGG TOOCTCCAGT 
1561GTCTGGGAGC ATCACCOCTG TGrfCCACCA GGAGATGTTG AACTATGTOC TATCTCCATT 
1621 CrACTACTAC CAGATCGAGC CCTGGAAGAC CCACATCTGG CAGAATGAGA AGCTGAGGCC
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1681CAGGAGGAGA GAGATŒGAT TTAGAGTCTT GGTGAAAGTG GTGTTCTTTG dTCCATGCT  
1741AATGCGAAAG GTCATGGCIT CACGGGTCAG AGCCACAGTC CrCîTTGCTA CTGAGACAGG 
1801 GAAGTCTGAA GCACTAGCCA GGGACCTGGC CACCITGTTC AGCTACGCCTTCAACACCAA 
1861 GGTTGTCTGC ATGGACCAGT ATAAGGCAAG CACCITGGAA GAGGAGCAAC TACTGCTGGT 
1921 GGTGACAAGC ACATTTGGGA ATGGAGACTG TCCCAGCAAT GGŒAGACTC TGAAGAAATC 
1981TCTGTTCATG CTTAGAGAAC TCAAŒACAC CTTCAGGTAT GCTGTGTTTG GCCTTGGCTC 
2041 CAGCATGTAC CCTCAGTTCT GCGCCTTTGC TCATGACATC GACCAGAAGC TGTCCCACCT 
2101 GGGAGCCTCT CAGCITGCCC CAACAGGAGA AGGGGACGAA CTCAGTGGGC AGGAGGATGC 
2161 CrTCCGCAGCTGGGCTGTAC AAACCITCGG GGCAGCCTGT GAGAOCTTTG ATGTCCGAAG 
2221CAAACATCAC ATTCAGATCC œAAACGCTT CACTTCCAAT GCAACATGGG AGCCACAGCA 
2281ATATAGGCTC ATCCAGAGCC CGGAGCCTTT AGAGCTCAAC AGAGCCCTCA GCAGCATCCA 
2341TGCAAAGAAC GTGTTTACCA TGAGGCTGAA ATCCCAGCAG AATCTGCAGA GTGAAAAGTC 
2401 CAGCCGCACC ACCCTCCTCG TTCAGCTCAC CTTCGAGGGC AGCCGAGGGC CCAGCTACCT 
2461GGCTGGGGAA CACCTGGGGA TCTTCCCAGG CAACCAGACC GCCCTGGTGC AGGGAATCTT 
2521GGAGOGAGTT GTGGATTGTC CFACAOCACA CCAAACTGTG TGCCTGGAGG TTCTGGATGA 
2581GAGCGCTACT GGGTCAAAGA CAAGAGGCTG CCCCCCTGCT CACTCAGCCA AGCCCTCACC 
2641 TACrrCCTGG ACATTACGAC CCCTCCCACC CAGCTGCAGC TCCACAAGCT GGCTCGCTTT 
2701GCCACGGACG AGAOGGATAG GCAGAGATTG GAGGOCTTGT GTCAGŒCTC AGAGTACAAT 
2761GACTGGAAGT TCAGCAACAA CCCCACGTTC CTGCATGTGC CCGCTGCCIT CCTGCTGTCG 
2821 CAGCTCCCTA TCTTGAAGCC CCGCTACTAC TCCATCAGCT CCTCCCAGGA CCACACCCCC 
2881 tCGGAGGTTC ACCTCACTGT GGCCGTGGTC ACCTACCGCA CCCGAGATGG TCAGGGTCCC 
2941 CTGCACCATG GTGTCTGCAG CACITGGATC AGGAAOCTGA AGCCCCAGGA CCCAGTGCCC 
3001 TGCnTGTGC GAAGTGTCAG TGGCITCCAG CTCCCTGAGG ACCCCTCCCA GCCTTGCATC 
3061CTCATTGGGC CTGGTACGGG CATTGCTCCC TTCGGAAGTT TCTGGCAGCA GCGGCTCCAT 
3121GACTCCCAGC ACAAAGGGCT CAAAGGAGGC CGCATGAGCT TGGTGTTTGG GTGCCGGCAC 
3181CCGGAGGAGG AŒA(XTCTA TCAGGAAGAA ATGCAGGAGA TGGTCCGCAA GAGAGTGCTG 
3241TTCCAGGTGC ACACAGGCTA CTCCCGGCTG ŒCGGCAAAC CCAAGGTCTA CGTTCAGGAC 
3301ATCCTGCAAA AGCAGCTGGC CAATGAGGTA CTCAGCGTGC TCCACGGGGA GCAGGGCCAC 
3361 CTCTACATTT GCGGAGATGT GCGCATGGCT CGGGATGTGG CTACCACATT GAAGAAGCTG
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3421GTGGCCACCA AGCTGAACTT GAGCGAGGAG CAGGTGGAAG ACrATTTCTT GCAGCTCAAG 
3481AGCCAGAAAC GTTATCATGA AGATATCTTC GGTGCAGTCT nT Œ TA T G G  GGCAAAAAAG 
3541 GGCAGCGCCT TGGAGGAGCC CAAAGCCACG AGGCTCTGAC AGOCCAGAGT TCCAGCTTCT 
3601GGCACTGAGT AAAGATAATG GTGAGGGGCT TGGGGAGACA GCGAAATGCA ATCCCCCCCA 
3661 A G C œ crC A T  GTCATTCCCC CCTCCTCCAC CXTACCAAGT AGTATTGTAC TATTGTGGAC 
3721TACTAAATCT CTCTCCTCrC CTCCCTGCCC TCTCrCCCIT TCCTCCCTTC TTCTCCACTC 
3781 CCCAGCTCCC TCCTTCTCCr TCTCCrCCTT TGCCTCTCAC TCTTCCTTGG AGCTGAGAGC 
3841AGAGAAAAACTCAACCTCCT GACTGAAGCA CnTGGGTGA CCACCAGGAG GCACCATGCC 
3901 GCCGCrCTAA TACTTAGCTG CACTATGTAC AGATATTTAT ACTTCATATT TAAGAAAACA 
3961 G A T A C m T G  TCTACTCCCA ATGATGGCTT GGGCTTTCCr GTATAATTTT CCTTGATGAA 
4021AAATATTTAT ATAAAATACA TTTTATnTA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA 
4081 AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAA
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Chapter 4
Inducible Nitric Oxide Synthase Gene Targeting
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4 . 1 .  Introduction
The targeting of the iNOS gene in ES cells is a mechanism to introduce specific 
mutations into the murine genome. Analysis of the phenotype of mice carrying such a 
targeted mutation can provide an insight into the biological role of iNOS, the functions of 
which had previously been largely a matter of speculation. Along with iNOS cDNA 
cloning, genomic cloning and restriction mapping are crucial factors in the construction of
a gene targeting construct for homologous recombination in ES cells. In this study, 
genomic DNAs from two mouse strains (B6  and 129/sv mice) were used for cloning of
'
iNOS-specific fragments and were mapped by restriction enzymes. The most commonly 
used targeting vector is a replacement vector, and this type of vector was used in the 
iNOS targeting work. Both 5' and 3' external probes were used to screen for the gene 
replacement event after recombination in an ES cell line. The mutated ES cells were 
injected into blastocysts to generate chimeric mice, which were then mated with test
breeding mice (MFl) to test for germ line transmission. This was conveniently analysed
...v;
by examination of offspring coat colour. Heterozygous mice were subsequently mated to 
generate homozygous mice. In the iNOS gene targeting described in this chapter, an 
unpredicted gene-rearrangement event occurred, which made it difficult to analyse the 
iNOS-deletion genotype. The detail is described below.
4 . 2 .  Mouse iNOS genomic DNA cloning and gene mapping
Two libraries were analysed, a B6  X, EMBL 4 genomic library (a gift of Dr. W, 
Mullar, Genetic Research Institute, University of Cologne) and a 129/sv X DASH 
genomic library (obtained from Dr. Austin Smith, AFRC, COR, University of 
Edinburgh). Both libraries were screened with a J774 cDNA 5’ EcoRI fragment (937bp) 
(Fig. 4.1).
One positive colony was obtained from the B6  mouse library, while another three 
positive colonies were obtained from the 129/sv library. The X DNAs were purified and 
restriction enzyme mapping was carried out with Bam H I, Bgl II, EcoR I, EcoR  V, 
Mwdlll, Kpnl, Pstl, S a d , Smal, Spel, Xball. The four genomic lambda clones
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from B6  and 129/sv libraries overlap and cover about 21kb of iNOS genomic DNA. The 
above restriction enzymes sites are identical for the two different mouse strains examined. 
The sizes of genomic DNA fragments and restriction enzyme map are shown in Fig.4.2.
To locate iNOS introns and exons, a number of Southern blot experiments were 
carried out. In addition, genomic subcloning and partial DNA sequencing was carried out 
in this study. 6.0kb, 2.8kb, 2.2kb, 1.4kb BamHI fragments; 7.5kb, 4.5kb, 4.2kb, 
2.2kb EcoR  I fragments and 3.8kb, 1.6kb, 0.8kb Psi I genomic fragments were 
subcloned in BamW I, EcoK I and Psi I sites of pBlueScript respectively. The whole 
sequence was completed for a 4.2kb EcoR. I subclone which covered the iNOS promoter 
and exon 1 and 2 (Fig 4,3.). The exons 3, 4, and 5 were obtained from a 6.0kb BamH I 
subclone and located by Southern blot analysis and DNA sequencing. The exon-intron 
junctions for exons 1-5 and 7 are shown in table 4.1. Most of these 6  intron-exon 
boundaries conformed to the known GT/AG donor/acceptor site rule, essentially 
maintaining the consensus sequence described by Mount (Mount, 1982) Exons 6  and 7 
were found in 2 .8 kb and 1.4 kb BamW I subclones, but the exon 6  junction was not 
sequenced. Half of exon 8  was identified by the terminal sequence of 7.5kb EcoR I 
fragment subclone. In total, eight iNOS exons (from exon 1 to 8 ) and the promoter were 
found spanning some -'21kb of genomic DNA. These eight exons are quite small (from 
70bp to 156bp in the first seven exons), and they only contribute 937bp of iNOS cDNA
%
(Fig 4.4). The start codon for iNOS translation is located in exon 2. From exon 2 to exon 
3, there is a large intron in between, which is about 5.5kb.
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Table 4.1.The intron-exon junctions of murine iNOS genome.
3' Intron Exon size 5' Intron
tggccccaCG GGACACAGT 128bp (Exonl) TCAACTGCAAG GTGAGTctt
cccttcctcAG AGAACGGAG 156bp (Exon2) GCTGTTCTCAG CCCAACaat
tcctttcgcAG CCCAACAAT 70bp (Exon3) GGACAGCACAG GTCAGTggt
acccattttAG AATGTTCCA 121 bp (Exon4) CGGCCACATCG GTAAGAagtc
ccttttccAG GATTTCACT 149bp (ExonS) CCTTTAAAGAG GCAAAAata
gtgccctgTG CAGGTCTTT 97bp (Exon7) GTCAACATCAG GTGAGGcacc
(Y)nNYAG GTRAGT
3' Acceptor 5' Donor
4 . 3 .  Positive-negative selection constructs for iNOS gene targeting
A variety of strategies have been used to increase the number of positive clones 
arising from homologous recombination above the background of clones surviving 
selection. The most widely used of these, developed by Mansour (Mansour et «/.,1988) 
uses a second, negative selection step, in addition to the positive selection afforded by the 
neomycin resistance encoding gene(wec? gene) insertion. The transcriptionally active 
Herpes simplex virus thymidine kinase (HSV-tk) gene when present in eukaryotic cells is 
not in itself, toxic to the cells. However, in the presence of the synthetic guanine 
analogue, ganciclovir (9-( 1,3-dihydroxy-2-propxymethyl) guanine) or the uracil 
derivative FI AU [l-(2-deoxy,2-fluoro-p-d-arabinofuranosyl)-5-iodouracil], toxic 
metabolites are produced by the viral enzyme, which interfere with cellular DNA 
metabolism and ultimately, kill the cell. The idea is that an HSV-tk gene cassette is 
engineered to one or both sides of the DNA sequence (consisting of a neo gene, the 
targeted gene and flanking sequences) expected to be inserted following homologous 
recombination. In the event of homologous recombination, the HSV-tk cassette is 
excised. Thus, addition of ganciclovir or FI AU has no effect and the cell survives. If the 
targeting vector is inserted randomly, the HSV-tk gene is likely also to be included.
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Addition of selection drugs will kill the cell. However the selection on the basis of G418 
resistance alone would not have distinguished between the random and homologous 
events. The homologous recombination should be identified by Southern blot 
hybridisation using the external probes. Because the external probes could not hybridise 
with targeting construct, the band should the size would be expected due to gene targeting 
event. Using a PCR screening strategy, it is theoretically possible to screen more colonies 
in a relatively short space of time.
In this study, two constructs were made based on the positive-negative selection 
strategy and PCR screening. The two constructs are exactly same except for the length of 
5' homologous region. One of the constructs has an 850bp 5' homologous region and is 
used as a positive control for PCR screening. This can be transfected into an ES cell line 
to generate one copy of construct B integrated into a chromosome. One of the PCR 
primers is located in the neo gene (reverse primer) of both constructs A and B, while the 
other primer is in the 5' homologous region of construct B and cLnnot hybridise with 
construct A (Fig. 4.4). In this way, if homologous recombination occurred, an 800bp 
PCR fragment should be generated by PCR from the ES cell clone that had undergone 
homologous recombination. This homologous recombination can be confirmed by 
Southern blot experiments with either an external or internal probe. In this gene targeting 
construct (construct A) most of exon 3 and a small fragment of the intron was replaced 
with the l.lkb  neo gene (Fig.4.5).
In the event, this iNOS gene targeting strategy was not used in this study, because 
the 3.9kb 3' homologous region of the construct was too short to give a high enough 
degree of the homologous recombination. In addition the small fragment of exon 3 
deleted may not be large enough to disrupt completely iNOS function. To avoid these 
disadvantages, another construct was designed with genomic DNA derived from 129/sv 
mice.
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Fig.4.5. iNOS gene targeting strategy for B6 mice. In construct A, the 5' homologous region was 
constructed using a PCR fragment generated with primers BB214 and BB179, the Clal and Xhol 
sites were created in the primers. In construct B, the 5' homologous region was generated by PCR 
with primers BB215 and BB179, withC/a I and Xho I sites in the PCR primers. The 3' homologous 
region for construct A and B were same and was generated from a 250bp PCR fragment (from primers 
BB180 and BB181) and a 3.75kb Kpn l-BamUX genomic DNA fragment. Both construct A and B 
were linearised with Cla l. The arrows in the map show the PCR primers (BB216 and BB217) used 
for the for detection of homologous recombination. The sequence o f the PCR primers used for the 
constructs and homologous recombination PCR screening are shown below:
BB179 : AGGGTCCTCGAGTATTGTTGGGCTGCGAAAGG 
BB214 : TGGAATCGATGCACrCAAGAAGCCCTGGCAAG 
BB215 : GAGTATCGATGAOCTTGAACrCCTGATCCCCC 
BB180 : TGGTTTGGATCCACAGTATGGAAGCCCTTCAT 
BB181 : TACTTAGGTACCAGCGCACCCT 
BB216 : CCTGCCITTGTTCCrTTCACrrcnTA 
BB217 : TCGCCTTCTATCGCCTTCTTGACGAG
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4 . 4 .  No detectable inducible nitric oxide synthase in ES cell
The absolute frequency of homologous recombination per electroporation per cell 
is quite low, commonly of the order of < 10 ' 6 , so that selection and rapid screening 
are necessary in order to discriminate between homologous recombination and the more 
commonly occurring non-homologous integration. "The promoter trap" is one of selective 
methods developed to enrich the ratio of homologous recombination in screening resistant 
colonies. The selection marker gene (the neo gene is commonly used as a selection 
marker), lacking its own promoter, can be expressed either as a fusion protein containing 
target gene sequences which nevertheless can retain the ability to confer geneticin- 
resistance (Schwartzberg, et al. 1989; Charron et al. 1990; Stanton et al. 1990), or as a 
result of reinitiation of translation of a polycistronic mRNA transcribed from the target 
gene promoter (Doetschman, et al. 1988). By this method, between one and three out of 
ten resistance colonies could carry homologous recombination events rather than the 1 in 
100-1000 normally expected. Using picomaviral internal ribosome-entry site (1RES) to 
provide cap-independent translation of a selectable marker from fusion transcripts 
generated following homologous recombination, up to 8 6 % of screened colonies has 
undergone homologous recombination (Mountford et al.., 1994). The design of the 
targeting vector for promoter trap experiments is dependent on the targeting gene being 
expressed in ES cells. So detection of iNOS expression in ES cells with or without 
stimulation became necessary.
2x10^ 129 ES cells (CGR8 ) were stimulated with or without 100 units IFN-y, 
lOng EPS or IFN-y/LPS respectively. The supernatants from the cultures of ES cells 
were used for NO2 measurement by the Greiss reaction as described in Chapter 2 (2.32.). 
No NO2 was detectable in any of the supernatants.
Both pairs of PCR primers corresponding to the iNOS cDNA 5' and 3' ends 
(described in Chapter 3-2) were used to amplify the mRNA from ES cell. iNOS mRNA 
could not be detected in the CGR-8  ES cells with or without cytokine stimulation. So, 
unfortunately the promoter-trap strategy could not be used for iNOS gene targeting.
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4 . 5 .  A large deletion positive-selection construct
To avoid the disadvantages of the initial gene targeting construct, another 
construct, with a larger deletion of the iNOS gene and longer homologous arms was 
made. Because the presence of base sequence divergencies between donor and recipient 
target DNA can reduce the efficiency of gene targeting (Riele, et al., 1992), this construct 
was made with 129-derived iNOS genomic DNA. The 5' and the 3' homologous arms of 
the construct were B.Okb and 3.6kb respectively. ll.Skb of iNOS genomic DNA, 
including exons 1-5 and part of the promotor, were replaced with 1.7kb of p-actin 
promotor and m o  gene. To avoid the possibility of iNOS repressor sequences which 
may have suppressed neo gene expression, the p-actin-weo gene was reversed with 
respect to the iNOS gene in the gene target construct (Fig.4.6). To generate an efficient, 
economic and convenient Southern blot screening protocol for the gene replacement 
event, a Hind III site was created by insertion of a double stranded oligonucleotide into 
the BamH I site between the 5' arm and the p-actin-Mgo gene as described in Chapter 2 
(2.14). The oligonucleotide sequences were BB60: CTATAGTTCGAACTAG, BB61: 
TTCGAACTATAGCTAG. The construct was linearised with S a d  sites in both 
homologous region (Fig.4.6).
4 . 6 .  The design of 5' and 3' specific external probes
The 1.4kb Sal l-Sac I DNA from a 5' genomic subclone was used asTable 4.4
e a 7.0kb single band for the Hind III digestion and an approximately 12kb single 
band for the BamH I digestion of normal ES cell chromosomal DNA in Southern blots 
(Fig.4.7). Because the external probe cannot hybridise with the targeting construct, only 
an homologous recombination event should show an additional hybridising band which 
should be reduced in size from 7.0kb to 5.4kb. Any random integration event will not 
give this band. The single signal from this 5' external probe.also indicated that the 5' 
region of the iNOS gene is unique in the 129 genome.
Both O.Skb and 1.2kb Pst I fragments from 3' specific genomic subclones were 
initially tested as the probes to detect the targeting event. However, both probes gave a
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Fig 4.7. Southern blot analyses to select functional external probes. ES cell 
genomic DNAs were digested with either Hind III (lane 1,3,5,?,) or BamH I 
(lane 2,4,6,8,) and hybridised with a 1.4kb Sal\-Sac I genomic fragment as a 
5'-specific external probe.
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smeared hybridisation pattern in both EcoRI digestion and EcoRY genomic Southern 
blots, indicating non-specific hybridisation (Fig.4.8). Terminal DNA sequence analysis 
was carried out with T7 and T3 universal primers for the O.Skb and 1.6kb Pst I subclones 
(Fig.4.3), and exon 7 of iNOS was identified. Two PGR primers (BB321 and BB322) 
were designed according to the sequence of the introns flanking exon 7 to generate a 
300bp product.
BB321: TGACCTGTAGAAGAAATGCCCTCTGTCC 
BB322: CCTCTCCTGTGCTCTCCAGCATCTTCTTCC
This 300bp PGR fragment was purified from an agarose gel to make the 3' 
external probe, which gave a single 7.5kb band with EcoR I digested DNA or 6.5kb band 
with EcoR V digested ES cell chromosomal DNA (Fig.4.9). Following a targeting event 
on additional hybridising fragment of 6.0kb should be obtained with EcoR I digested 
DNA (but not in DNA with a random integration event). The expected Southern blot 
bands given by both 5' and 3' end probes would indicate whether or not the correct gene 
replacement event occurred. If only one of them gave the expected recombinant band, 
then the double cross-over event would not have occurred. However, the gene may still 
be targeted and it may be sufficient to cause a gene defect. The position of the 5' and 3' 
end probes are shown in Fig.4.10.
4 . 7 .  Selection and screening of ES cell lines for iNOS gene targeting
In this study, the GGR-8  ES cell line (Mountford. et al., 1994) was electroporated 
with linearised targeting construct DNA. After 8  days of G418 selection, single colonies 
were isolated and then were divided into two, one for gene screening and another for a 
freeze-stock. Half of the sample was used to make chromosomal DNA plugs which were 
digested with Hindlll, and the other half with EcoRI. The 5' specific external probe was 
used for the first hybridisation screening. One clone (No. 133) showed the expected 
additional hybridisation band for a homologous recombination event. This clone also 
gave expected fragment with 3' external probe, apparently confirming the replacement 
(Fig.4.11).
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a. b.
Fig.4.8. Southern blot analyses to select a specific external probe for the 3'- 
targeting event. ES cell genomic DNAs were digested with either EcoR 1 (a. 
lane 1,3,5,7, and b. lane 1') or EcoR V (a. lane 2,4,6,8, and b. lane 2’) and 
hybridised with either a 1.2kb Psi 1 fragment (a.) or a O.Skb Psi 1 fragment 
3' end probe (b.).
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-7.5kb
-6.5kb
Fig.4.9. Southern blot by using a 300bp PCR fragment as a 3* end external 
probe to hybridise with ES cells DNAs digested with either EcoR V (lane
1,3,5,) or EcoR 1 (lane 2,4,6,)
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Mammalian embryos are extremely résiliant in the early stages of their 
development and can not only tolerate abuse or loss of tissue, but can also functionally 
incorporate cells from other embryos. This property of mammalian embryos, the ability to 
incorporate foreign cells during development, has been exploited for several purposes 
including the elucidation of cell lineages, the investigation of cell potential, and the 
perpetuation of mutations produced in ES cells by gene targeting. The cells from two 
embryos which contribute to one body is called a chimera. The foreign cell, with specific 
gene mutation, can go through the chimera's germ line to the offspring and this is known 
as germ line transmission.
The identified iNOS gene targeted 129/sv ES cells (No. 133), were injected into 
C57 Black 6  blastocysts. These blastocysts were then transplanted into the uterus of 
C57xCBA FI pseudopregnant mice (This was done by Jan lire in Gene Targeting 
Laboratory, Centre for Genome Research, University of Edinburgh). The coat colour is 
the indicator for the quantification of chimeras. Good chimeras have more agouti coat 
colour (which was contributed by 129 ES cells) than the black coat colour from 
C57black6 embryos, but germ line transmission need not necessarily arise from good 
chimeras. The 129 ES cells were from the inner cell mass of male blastocysts, so the 
majority of good chimeric mice were males rather than females. Germ line transmission is
106
Re-hybridisation of the Hindlll digestion Southern blot with a neo gene probe, 
showed one copy of the neo gene was present. In this iNOS gene targeting experiment, 
only a single targeted clone was identified from 636 screened samples after two 
independent electroporations.
Before the blastocyst injection, the chromosomes were stained and the number 
was counted under the microscope. 80% of ES cells had 40 chromosomes which 
indicated that the line was normal and should contribute to generate chimeras and give 
germ line transmission.
!
4 . 8 .  Production of chimeras and germ line transmission to offspring
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a crucial step in the generation of gene targeting mice. Test breeding the chimeras with 
MFl female mice is the easiest way to detect the germ line transmission and can be 
analysed by the coat colours of the offspring. 129xMFl offspring give a grey coat colour 
that means germ line transmission has occurred. However a black colour from C57 Black 
6  x MFl means transmission has not occurred. In this study, 10 chimeras were generated 
from two injections and 5 of these gave germ line transmission. In ES cells, there are two 
pair sets of chromosomes (from both parents) and both can form the germ cells to give 
grey coat colour of the offspring. However, the gene mutation is introduced into only one 
of pair sets, so 50% of grey mice should carry the gene mutation which was made in the 
ES cells. To find out the number of grey mice with the iNOS gene mutation, their tails 
were tipped, DNAs were purified and digested with Hindlll for Southern blot analysis 
with the 5' specific external probe. Of the 59 mice analysed, 30 offspring were 
heterozygous.
4 . 9 .  Segregating genotypes
The heterozygous mice identified in the above procedure can normally be mated 
together to produce litters with, wild type normal, heterozygous and homozygous mutant 
mice. Five matings were set up with one male and two females heterozygous offspring 
(FI) in each group. All 97 offspring (F2) were genotyped with the 5' specific external 
probe. The number of wild type : heterozygous : homozygous was 25:72:0. It was 
considered at this stage that perhaps the mice with the homozygous mutation genotype 
were lost during the embryo development.
4 . 1 0 .  Investigation of the homozygous embryos during development
To find what was happening to the homozygous mice, heterozygous mice (F2) 
were used in a time mating experiment. After mating, the vaginal plugs were checked. If 
vaginal plugs were found, the mice had mated and the gestation time was taken as 0.5 
day. By 10.5, 13.5 and 14.5 gestation days, the murine embryos were removed. Most of 
the 70 embryos analysed developed normally except for 2 absorption embryos. In
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addition some embryos showed excessive blood. The litter sizes were quite normal, 
suggesting that a quarter of the homozygous mutant mice were not lost in the early 
development. The yolk sacs were isolated and DNA was purified for hybridisation with 
the 5' specific external probe to genotype the animals. None of the homozygous genotype 
was found in all 70 embryos analysed from 6  litters. Strangely, the mice with 
heterozygous genotype were found in numbers much greater than 50%. In some litters, 
100% of mice had the heterozygous genotype (Table 4.2). This finding indicated that 
either the iNOS gene mutation caused enhanced activity of germ cells or alternatively 
some of the heterozygous genotype mice were in faet homozygous for the presumed 
replacement event, but also that the wild type allele was still detectable for some reason 
(All the heterozygous genotypes discussed above are based on the 5' and 3' specific 
Southern blots experiments). This strange observation could be explained if, for some 
reason, the iNOS gene had duplicated. The mice (F2) used for the time mating were all 
the offspring from FI heterozygous genotype intercross, so some of F2 mice could have 
been homozygous for the mutant genotype which could not be detected with the external 
probe. This idea was confirmed later by a back-cross study.
The Pairs Gestation Days Litter Size W.T. Het. Homo.
MAX13-2A 10.5 9 0 9 0
11-AX33-2A 10.5 12 5 7 0
4BX34-1A 10.5 9 3 6 0
1CX41-1A 10.5 15 0 15 0
11CX40-1A 12.5 13 0 13 0
4-1AX30-1A 13.5 12 0 12 0
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4 . 1 1 .  Identification of the homozygous mice by back-crossing
Why were so many mice embryos with a heterozygous genotype generated from 
F2 heterozygous mice? To answer this question, some of the F2 males and females with 
heterozygous genotypes were mated with the females and males with a wild type MFl 
background mice respectively (this was called a "back cross"). The offspring of the "back 
cross" were genotyped with the 5' specific external probe in Southern blot experiments. 
One male (EM: IIC) and two females (EM: 14C and 31C) with an appaient heterozygous 
genotype gave 100% heterozygous genotype offspring (F3) while the rest of them gave 
about 50% heterozygous (Table 4.3). The result indicated that the mice that gave 100% 
transmission were in effect homozygous which meant that both of the chromosomes had 
an iNOS gene replacement mutation. This result ruled out the suggestion of the super 
ability of sperm. The conclusion from the results obtained above was that iNOS mutant 
mice were not lethal in homozygous mice during embryogenesis.
Table 4.3. The genotype of offsprings from F2 back-cross.
The ear Mark No. Sex Litter Size WT. Heter (% )
l i e male 15 0 15 100
IOC male 8 5 3 37.5
1C male 9 + 8 7 10 58.8
30C female 13 7 6 46.2
14C female 13+12 0 25 100
31C female 14 0 14 100
4 .1 2 .  iNOS gene duplication after gene targeting
Why was the wild type allele still detectable in the homozygous mice after the 
replacement event? (the homozygous animals discussed here are based on the "Back 
cross" analysis). Either there were two copies of the iNOS gene in the murine genome or 
the gene had been duplicated during the gene targeting event. To try to answer this
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question, both 5' and 3' specific external probes were used in Southern blot experiments 
with DNA digested with different restriction enzymes. DNA samples from wild-type, 
heterozygous, and homozygous mice were analysed. The restriction enzymes were 
chosen in homologous recombination regions of the construct. The homologous 
recombination should not change the restriction enzymes sites in the homologous 
recombination regions and flanking sequence. If there was a duplicate gene in wild type 
mice, double bands should appear with some restriction enzymes. This should also 
appear in iNOS gene targeting mice. Unexpectedly, after certain digests, the 5' external 
probe gave two hybridising bands in heterozygous and homozygous, but not in the wild 
type mice. This result suggested that iNOS gene duplication was the result of the gene 
targeting. There is no evidence for the existence of the duplication copies of the iNOS 
gene in the mouse as there is in man and the great apes (Xu, et aL, 1995).
For the 5' external probe hybridisation. Sac I Pstl, Spe I BamHl and Kpnl were 
used to digest the tail DNA from wild-type, heterozygous and homozygous mice. The 
Sad  and Pstl digests gave the single hybridisation band respectively. However, the Spel, 
BamHl and Kpnl gave two bands in heterozygous and homozygous but not in wild-type 
(Table 4.4). This result indicated that change of restriction enzymes sites had occurred 
^2.3kb upstream of the5'ac I site after the gene targeting event (Fig.4.12). Using the 
300bp and 400bp 3' specific external PCR probes [400bp PCR fragment probe was 
amplified from a lA kh  BamH I subclone (Fig.4.3)] in Southern blot. The Sad  gave 
single hybridising band and the Bglll gave two bands (because there is Bgl II site in 
between of two PCR probes) in all genotypes of mice. However, the Kpnl and Hindlll 
digestion gave two hybridising bands in heterozygous and homozygous mice but not in 
the wild-type mice (Table 4.4.) This result indicated that the change of enzyme sites had 
occurred approximately 5.0kb down stream of the EcoR I site (Fig.4.12). All the above 
Southern blot results suggested that part of the iNOS gene had been duplicated after gene 
targeting. Either both 5' and 3' ends of targeting construct extension copied the targeting 
gene and integrated, or part of the iNOS gene had integrated somewhere after the gene
110
________________
replacement. The two possibilities could not be distinguished by the 5' and 3' specific 
external probes.
Enzyme 5' external probe 3' external probe
W.T. Hete. Homo W.T. Hete. Homo
BamH I 1 2 .0 kb 1 2 .0 kb
9.5kb
1 2 .0 kb
9.5kb
B glll 7.0kb
l,9kb
7.0kb
1.9kb
7.0kb
1.9kb
Hind III 1 2 .0 kb
ll.Okb
1 2 .0 kb
ll.Okb
1 2 .0 kb
ll.Okb
Kpn I 6.5kb 6.5kb 6.5kb lO.Okb lO.Okb lO.Okb
13.0kb 13.0kb 1 2 .0 kb 1 2 .0 kb
P^t I S.Okb S.Okb S.Okb
5'«cl 2.3kb 2.3kb 2.3kb 3.6kb 3.6kb 3.6kb
Spe I 6 .0 kb 6 .0 kb
5.5kb
6 .0 kb
S.Skb
4 . 1 3 ,  The expected deletion had not occurred.
To find out whether or not the ll.Skb iNOS gene fragment was deleted by the 
gene replacement, an internal probe (1.2kb Hindlll-EcoRl fragment located in the 
expected deletion area) was used as internal probe for Southern blot analysis with Hindlll 
digested genomic DNA samples from mice with wild-type, heterozygous and 
homozygous genotypes. 4.0kb hybridisation bands were detectable in all these mice with 
three different genotypes.
Three oligonucleotides were synthesised for the PCR strategy to identify the 
genotypes. One primer (P2) is in the 3' end of the gene targeting construct which will 
bind to both the wild type gene and the replacement construct. The other two bind either
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to the neomycin gene (PI) or the expected deleted area of the iNOS gene (P3) (Fig.4.10). 
The primers sequence are shown below.
PI: GCGGCCGGAGAACCTGCGTGCAATCC (CB843)
P2: CAGAGTAGGAGGTTGAGACCCAATG (CB844)
P3: GCTCCTGCCTCATGCCATTGAGTTCA (CB845)
P2 and P3 amplified a 300bp PCR fragment for the wild type allele, while the P2 
and PI primers give an SOObp product for the knockout allele. Unfortunately, the wild 
type allele was detected in all the homozygous mice. Both PCR and Southern blot results 
showed that the expected deletion had not occurred although the external probes showed 
homologous recombination had occurred.
4 . 1 4 .  The murine iNOS gene rearrangement and mutation
All the above evidence showed that on the one hand, a homologous recombination 
event had occurred, but that the expected deletion had not occurred. This can be explained 
it both ends of the targeting construct extension copied the flanking sequences, then 
integrated into the gene. To find out whether part of the wild type gene or the replacement 
gene targeting construct had been integrated elsewhere in the genome, the 1.2kb Hindlll- 
EcoRI internal probe was used in Southern hybridisation experiments (Fig. 4.12). This 
probe does not hybridise with the replacement gene targeting construct. The Southern blot 
with EcoRN digested DNA showed that ~14kb wild type allele disappeared and was 
replaced by an approximately 16kb hybridisation band in the homozygous mice 
(Fig.4.13).
Using the 5' specific external and internal probes for Southern blot analysis, it 
was clear that two copies of the iNOS gene could be detected in the homozygous mice, 
but not in wild type mice. This result suggested two possibilities. One is that the wild 
type gene had not been changed but the targeting construct picked up about 2.3kb 5'-end 
sequence and 5.0kb 3'-end sequence which could hybridise with the 5' and 3' external 
probe respectively, and this was then integrated somewhere (which is shown as WT and 
A in the top map of the Fig.4.12). Another possibility is the targeting construct replaced
112
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the iNOS gene, however the replaced region of the iNOS gene plus flanking sequences 
integrated elsewhere to generated a pseudo wild-type allele and caused the restriction 
enzyme sites {Kpnl, BamHl and Spel) change seen in the Southern blot analysis of the 
homozygous mice DNA (which is shown as B and Mut in the top of the map of 
Fig.4.12). The 5' specific external probe can not tell which event has occurred (WT and 
A or B and Mut). Using the 1.2kb Hindlll-EcoRL internal probe which only hybridises 
with the wild type gene (gives 14kb EcoRY restriction fragment), EcoRY  digested 
Southern blot analysis showed that an alteredEcoRV restriction fragment (16kb) was 
identified in homozygous and heterozygous mice, but not in wild-type and 129 ES cells 
(Fig.4.13), which indicated that a strain polymorphism is unlikely. Because EcoRY site 
is between the other two enzyme sites (Kpnl and Spel) which have been changed in the 
homozygous mice, so the duplication events are more likely to be the B and Mut 
(Fig.4.12) rather than WT and A. This result suggested that wild-type sequences are 
now contiguous with novel 5’ sequences i.e. either they have been transposed elsewhere 
in the genome or some rearrangement has occurred around the iNOS gene locus. Using 
the 1.2kb MMIH-EcoRl internal probe to detect the alteration in the iNOS gene, the wild 
type, heterozygous and homozygous mutation genotypes were identified in the offspring 
from FI heterozygous mating. The number of the three genotypes were 25:47:21 
respectively.
If a fragment of the wild type gene was transposed as a result of the homologous 
recombination event, it is possible that the iNOS gene expression could have been 
disrupted. In order to test this hypothesis, peritoneal cells were collected from 
homozygous and wild type mice and cultured in the presence of IFN-y and EPS. The 
cells were harvested 6 h or 8 h after activation, and total RNA isolated for the Northern 
blot analysis. Using the 937bp 5' iNOS cDNA probe, about /-4.0kb iNOS signal was 
detected in RNA extracted from both wild type mice and a murine macrophage cell line 
(J774, ATCC). A larger band of about 4.5kb was detected in RNA extracted from the 
homozygous mice (Fig.4.13).
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Fig.4.12. Using the both 5' and 3 ’ specific external probes to map the flanking 
regions of the iNOS gene by Southern blotting for DNA from ES cells, wild type, 
heterozygous and homozygous mice. The top map shows the 5' end and the 
bottom the 3 ’ end. Thé solid lines are the wild type iNOS genomic DNA, the 
dotted lines are unconfirmed region of the gene. The plain text enzyme sites were 
mapped with the cloned iNOS gene, th& Italic enzymes sites were mapped by 
Sothern blot. The bold Italic enzyme sites show the changes after gene targeting. 
The empty bars show the homologous arms.
_
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4 .1 5 . The iNOS transposition and replacement events may have occurred
■
in the same locus
i
I
The internal and external probes were used to attempt to detect the transposition 
and replacement events respeetively. Tail DNA isolated from the offspring of the back- 
crossing experiment (Chapter 4.11) was digested with EcoR  V, Hindlll and EcoRl 
respectively. A Southern blot with EcoRV digested DNA was hybridised with the internal 
probe, while the Hindlll and EcoRl blots were probed with the 5’ and 3' external probes 
respectively. Analysis of DNA from 92 offspring from the back-crossing, showed that 
the replacement and translocation events were always detected in the same mouse's tail 
DNA. This strongly suggests that the two events Le, translocation and gene replacement 
are linked.
4 . 16 .  No detectable iNOS protein in homozygous mice by Western blot
Both peritoneal and spleen macrophages from wild type mice and homozygous 
mice were cultured and stimulated with IFN-y and LPS under the conditions reported 
earlier (Liew, et aL, 1991). Western blots were carried out in four separate experiments 
with monoclonal (Fig4.13) and polyclonal (Fig.4.14) anti-iNOS antibodies, A distinct 
band at Mr 130k was seen in the samples from wild-type mice and control J774 cells , but 
no protein band was visible in the samples from the homozygous mice.
4 .1 7 .  Culture supernatant N02" measurement by the Greiss method
Peritoneal macrophages were cultured and stimulated with IFN-y and LPS. High 
concentrations of nitrite were detected in cultures of the activated cells from wild-type and 
heterozygous mice, whereas no nitrite was detected in the cultures of cells from the 
homozygous mice at 24 hours (Fig.4.13). By 72 hours, however, a low level of nitrite 
was detectable in the supernatant of cells from the homozygous mice while no detectable 
nitrite was detectable from unstimulated control cells. They may reflect the accumulation 
of nitrite produced by increased calcium-dependent NOS, which has recently been shown 
to occur in J774 cells and can be increased markedly by LPS (Dusting, et aL, 1995)
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Fig 4.13. (a) Southern blet analysis. Genomic DNA isolated from the tail tips of offspring of 
heterozygous into'crosses were digested with EcoRV and hybridised with a 1.2kbEcoRI-//i/idIII fragment 
as an internal probe. The wild-type allele migrates as a 14kb fragment, while the mutant is 16kb. (b) 
Northern blot analysis. Total RNA was extracted from peritoneal macrophages after activation with INF-y 
and LPS. The bands from wild-type and J774 cells are about 4.0kb, while the bands from mutant mice are 
about 4.5kb. (c) Western blot analysis. Protein extracts from the macrophages after 18hr activation with 
IFN-y and LPS and stained with monodonal anti-murine iNOS antibody. The wild-type and J774 cells 
showed bands about 130kd, while no detectable band a{ )^eared in activated macrophages from mutant mice, 
(d) The culture supernatants of macrophages from wild-type, heterozygous and mutant mice were collected 
at 24 hours after stimulation with IFN-y and LPS, and assayed for nitrite by the Griess method Vertical 
bar=lSD, n=3.
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Fig.4.14. Western blot analysis. Protein extracts from the macrophages at 
20 hours after stimulation with IFN-y and LPS and stained with polyclonal 
anti-murine iNOS antibody. The wild-type and heterozygous mice show 
strong bands about 130kd, while no detectable band appeared in activated 
macrophages from mutant mice.
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4 . 1 8 .  Summary
In this study, an iNOS gene mutation was introduced into the 129 ES cell line by 
neo gene replacement of the ll.Skb region of the iNOS spanning exons 1-5. The deletion 
also removed half of the promoter. A single targeting clone was identified from 636 
screened after two independent electroporations experiments of the CGR8  embryonic 
stem cell line. Germline transmission was obtained for five of ten chimeras analysed. The 
gene replacement event was identified with both S' and 3' specific external probes. 
Intercrossing the heterozygous offspring (FI) from the germ line transmitting chimeras, 
however demonstrated that the wild type gene specific band persisted in the offspring 
(F2) of the heterozygous breeding. Back cross experiments with heterozygous F2 mice 
and M Fl wild type mice demonstrated that some of heterozygous mice gave 100% 
heterozygous genotype transmission, while the others gave about S0 % heterozygous and 
S0% wild genotypes. The back-cross results indicate that the iNOS gene or at least part of 
it had been duplicated. Southern blot analysis, using different restriction enzyme digests 
of genomic DNA from ES cells, wild type mice, heterozygous and homozygous mice tail 
DNA respectively, showed that the part of iNOS wild type gene had been duplicated after 
the gene replacement event. Using a specific internal probe which should only hybridise 
with the wild type gene, demonstrated that a -'14kb band found in wild type animals and 
129 ES cells was replaced with a ^16kb mutant band in the homozygous mice. DNA 
from heterozygous animals showed two bands at about 14 and 16kb. The ratio of wild 
type, heterozygous and homozygous was normal (25:47:21). Southern blot experiments 
suggested that two separate gene rearrangement events could have occurred in the iNOS 
gene targeted mice. One involved the neomycin resistance gene replacing the ll.Skb of 
iNOS exons 1-5, the other involved part of the iNOS gene transposition. These events 
appeared to cause the iNOS gene deficiency resulting in no detectable iNOS protein 
translation. Similarly, no nitrite could be detected from the supernatant of the activated 
peritoneal macrophages from mutant mice within 24 hours. The conclusion from all of the 
above results is that iNOS mutant homozygous mice are viable and fertile. There is no 
evidence of histopathological abnormalities for the spleen, kidney, brain, lung, heart,
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lymphnodes, intestine from three homozygous mutant mice compared with three wild 
type mice ( this investigation was curried out by Dr. G Lindop in the Pathology 
Department of Western Infirmary, University of Glasgow).
Human iNOS genomic mapping showed that the human iNOS gene has 27 exons 
and introns through 37kb of genomic DNA (Xu, et aL, 1995; Chartrain, et al. 1994) In 
the study reported above, the genomic DNA mapping for the murine iNOS gene was not 
carried out completely, but it showed the same pattern. Only eight exons and the promoter 
were located in 21kb of three overlapping genomic clones. These eight exons contributed 
to 937bp of the 4.0kb of iNOS mRNA, A large part of the iNOS gene was not cloned and 
mapped in this study, which makes it difficult to understand exactly the gene 
rearrangement events that have occurred in the iNOS mutant mice. According to the 
Southern blot results, there were two possibilities. To understand the recombination 
events that occurred during the generation of the iNOS mutant mice further experiments 
are required. A homozygous genomic library has been made and a cDNA library will be 
made from mutant mice. Mapping the mutant iNOS gene and DNA sequencing of iNOS 
clones from the cDNA library will provide detailed information on the gene 
rearrangement. It is important to analysis the phenotype for the targeted gene. Normally 
these phenotypes have been demonstrated previously with the other techniques. Some of 
the functions suggested for iNOS have been experimentally supported by analysis of 
these iNOS mutant mice. This work is described in next chapter.
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Chapter 5
Biological Phenotypes of iNOS Mutant Mice .Si
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5 . 1 .  Introduction
Nitric oxide (NO) is a critical mediator of many biological functions, including
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endothelium-related vascular relaxation, platelet aggregation and neurotransmission, as 
well as in anti-microbial and tumoricidal activity of murine macrophages (reviewed in
1 -
Liew F.Y. et al. 1991, Moncada S. et aL 1991, Green S.J. et al. 1993). Cytokine- 
induced synthesis of NO from L-arginine is characteristic of many mammalian cell types 
and was first described in murine peritoneal macrophages (Stuehr, et a/., 1985). Since 
then, inducible nitric oxide synthase (iNOS), the enzyme which catalyses the conversion 
of L-arginine and molecular oxygen to L-citrulline and NO, has been purified, cloned,
and shown to be expressed by many other cell types, e.g., fibroblasts, endothelial cells, i
;:|
hepatocytes, articular chondrocytes, cardiac myocytes, and kératinocytes etc. Depending
on the cell types, the site of release, and also on the local NO concentration, the |t
generation of NO by iNOS may lead to diverse consequences. There is increasing
:
evidence that NO may play a key role in nonspecific defence mechanisms against 
pathogens, and may be involved in the signalling between macrophages and T cells
(Liew, et aL, 1991). In most cases, the biological role of NO has been demonstrated by 
using L-arginine analogous such as L-N^monomethyl-arginine (L-NMMA) to inhibit NO 
synthesis in vivo. L-NMMA is not NOS isoform-specific {i.e. it can also block the 
activity of ncNOS, ecNOS and arginase activity). The iNOS deficient mice constructed in 
this study have provided a powerful tool for obtaining direct evidence for the various
■ÿ.
biological functions of iNOS which had been controversial from previous experiments f
using the L-arginine analogues. In this chapter, the phenotype of the iNOS deficient mice 
in Leishmania infection, local inflammation and LPS-induced shock are described. ; i
5 . 2 .  Mice lacking iNOS have normal T cell functions
5.2.1. Spleen cell proliferation after ConA stimulation
■il
Spleens were harvested from group of 5 wild type or mutant mice. Single-cell 
suspensions were pooled for each group, resuspended at 2 x 10^ cells/ml, and dispensed at
' ■■ "lf;S
' . ':Ü
lOOpl/weli in flat bottom 96-well plates. ConA (0.1, 0.5, 2.5, 5.0 and 10.0p,g/ml) was
5-2-3: IFN-y and IL-4 produced bv spleen cells in vitro
122
added to each well and the cultures incubated at 37®C in an atmosphere of 5% CO2 .
Supernatant (100p,l) was collected at 17, 24,48 and 72 hours for cytokine measurement. 
pH]thymidine (IpCi/well) was added for the final 6  hours of incubation, then harvested 
and counted in a p-scintillation counter. There was no significant difference at all doses 
and time course tested in the proliferation of the spleen cells between iNOS mutant and the 
wild type mice (Fig.5.1). The optimal proliferation was at 5.0p,g/ml of ConA by day 2
after stimulation. |
:#
5.2.2. Analysis of spleen cells from immunologicallv naive mice
Spleen cells from four individual mutant and wild type mice were analysed for
CD3+, CD3+CD4+, CD3+CD8+ subsets by flow cytometry using the appropriate
antibodies. There was no significant difference in the percentage of CD3+, CD3+CD4+, 
or CD3+CD8+ subsets of T cells in the splenic population of untreated mutant and wild 
type mice (Fig.5.2).
: j:
Supernatant from spleen cell culture was collected at 17,24,48 and 72 hours after 
stimulation with 5pg/ml of ConA. Concentrations of IFN-y and IL-4 were measured by
'Mk
ELISA. IFN-y and IL-4 production reached plateau concentrations at day 2 and day 3 
respectively. There was no significant difference between the concentrations of IFN-y or 
IL-4 produced by the spleen cells from mutant or wild-type mice at all the times points 
treated (Fig.5.3).
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Fig.5,1. Proliferation of spleen cells from wild type (open triangle) 
and mutant mice (filled triangle); (a.) cultures were incubated for 2
days; (b.) cultures were stimulated with 5.0pg/ml of ConA. Vertical 
bars=lSD, n-3. Data are representative of two experiments.
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Fig.5.2. No significant difference in the percentage of CD3+, CD3+CD4+, or 
CD3+CD8+ subsets of T cells in the splenic population of untreated mutant mice (filled 
columns ) and wild type mice (open columns ). Vertical bars=lSD, n=5. Data are 
representative of 2  experiments.
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Fig 5 .3 . IFN-Y and IL-4 produced by spleen cells of mutant mice (filled 
columns) and wild type mice (open columns). The culture was stimulated 
with 5pg/ml ConA. Vertical bars=lSD, n=5. Data are representative of 2 
experiments.
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5 . 3 .  Mice lacking iNOS fail to control a Leishmania major infection
5.3.1. The Lesion of L. major infection
Anti-microbial activity of NO in vivo was previously suggested by reports which 
either documented high urinary excretion of nitrate in resistant mice infected with L. major 
(Evans, et aL, 1993) or progressive disease in animals treated with L-NMMA (Liew, et 
al., 1990), an inhibitor of both the constitutive and inducible type of NOS. Furthermore, 
using Northern blot, PCR and immuno-histological techniques, iNOS mRNA and protein 
were detected in tissue after the mice were infected with L. major (Stenger, et al., 1994), 
toxoplasma (Gazzinelli, et al., 1993), listeria (Boockvar, et al., 1994), or viruses 
(Korprowski, et al., 1993). In this study, iNOS mutant mice were used to provide a 
direct evidence for the functions of iNOS in L. major infection. Groups of 5 wild-type, 
heterozygous and mutant homozygous mice were infected in the footpads with 1x 1 0 ^ 
stationary-phase (day 7 culture) L. major (LV39) promastigotes. Lesion development 
was measured at regular intervals with a dial calliper and expressed as the footpad 
thickness increase of the infected right hind foot compared with the uninfected left hind 
foot. The wild type and heterozygous mice achieved spontaneous healing, but mutant 
homozygous mice failed to do so (Fig.5.4). The experiment was terminated (as required 
by the guidelines of animal experimentation of the Home Office, UK) when the lesion in 
the mutant mice became ulcerated. The healing wild type and heterozygous mice were in 
excellent health. The mutant mice had spleens and draining lymph nodes approximately 2 
to 3 times larger than those from the wild-type and heterozygous mice.
5.3.2. Parasite load of infected footpads
The foot pads of the mice infected with L. major were removed. Footpad tissue 
from the individual mice homogenised in 10ml PBS, and 50ul portions of suspension 
were sequentially diluted fivefold in Schneider medium containing 20% PCS. They were 
placed into flat-bottom 96-well plates and incubated at 28°C in humidified room air. 
Individual wells were examined daily using an inverted microscope for the presence of
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Fig.5.4. Footpads swelling differences at weeks after infection with 10^ L. major. The 
mutant mice (closed triangles) had significantly larger foodpads than those of the 
heterozygous (closed squares) and wild-type mice (open triangles). Vertical bars = ISE; 
n=5.
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motile promastigotes. The geometric mean (logio) and standard error of the last positive 
reciprocal dilution for each group was calculated. The result demonstrated a significantly 
higher parasite load in the infected footpads of homozygous mice than the wild-type and 
heterozygous mice (Table 5.1).
Tissue 5.1. Content of L. major in the infected footpad
Groups(n=3) ( Logio ±SEM )
Titre of viable L. major
Wild-type 3.82±0.8
Heterozygous 3.3 ±0.0
homozygous 6.09±0.4
5.3.3. T-cell analysis of mice infected with L. major
Spleen cells were harvested and pooled from 3 mice per group on day 70 after 
infection with L. major. They were analysed for CD3+, CD3+ CD4+ and CD3+ CD8 + 
subsets of T cells by flow cytometry using the appropriate antibodies (Table 5.2). Spleen 
cells from mutant mice infected with L. major contained a significantly higher proportion 
of CD3+ and CD3+CD4+ T cells than those from the infected wild-type and heterozygous 
mice. Figures underlined are significantly different (P<0.05) from those of wild type 
mice.
Table 5-2: T-cell analysis of spleen cells from mice infected with L. major___________
Splenic T cells (%) Wild-type__________ Heterozygous_______ Homozygous______
CJ3 3 + 16.9 19.1 22.2
CD4 + 7.7 11.9 16.8
CD8 + 4.0 3.9 3.1
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5.3.4. Spleen cell proliferation of mice infected with L. major
Spleen cells were also cultured at 1x10  ^cells per ml in flat-bottom 96 well-plates. 
Cultures were stimulated with graded concentrations (lO^-lO^ organisms equivalent per 
ml) of soluble L, major antigen which was prepared by 3x freeze-thawing and high­
speed centrifugation as described in Chapter 2 (2.37.). or Con A (0.5, 2.5 and 5.0pg/ml) 
for 1 to 4 days. The optimal proliferation of the cells from all three groups was on day 4 
at 10  ^organisms equivalent per mi of antigen, and on day 3 at 5pg/ml Con A (Table 5.3).
Table 5.3. Spleen cell proliferation after stimulation with L. major antigen and ConA
wild-type heterozygous mutant
L. major antigen 576±276 3374±644 20.833+5.640
ConA 17,676±6,010 9,261±1,592 6L812±9,982
* The data are mean±lSD, n=3. Figures underlined are significantly different (P<0.05) 
from those of wild type mice.
5.3.5. IFN-y and IL-4 production after stimulation with L. major anti gen in vitro
Spleen cells were also cultured at 1x10^ cells per ml with 10^ organisms 
equivalent per ml of soluble leishmanial antigen in 24-well plates. Supernatant was 
collected on days 1 to 4 and assayed for IFN-y and IL-4 by ELISA using paired 
monoclonal antibodies. IFN-y and IL-4 levels reached plateau concentrations at day 3 and 
day 4 after L, major antigen stimulation. The homozygous mice produced more IFN-y 
and less IL-4 than the wild-type and heterozygous mice (Fig.5.5).
5.3.6. Serum IgG types of mice infected with L. maior
Sera collected on post-infection day 70 were titrated against soluble L. major 
antigen-coated plates as described in Chapter 2 (2.40.). There was no significant 
difference in the anti-leishmania antibody among the three groups of mice. The 
concentrations of IgG2a were all higher than those of IgGl in three groups (Fig.5.6 )
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Fig.5.5. IFN-y and IL-4 productions by spleen cells after stimulation with 10^ 
organisms equivalent per ml of soluble leishmanial antigen (L. major). The spleen cells 
from mutant mice (filled columns) produced more IFN-y and less IL-4 than those from 
heterozygous mice (striped columns) and wild-type mice (open columns) by day 2  and 
day 4 after stimulation. Vertical bars=lSD; n=3.
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Fig.5.6. Serum IgG types of mice infected with L. major. There were no different 
partem among the wild-type (A), heterozygous (B) and homozygous mutant mice (C). 
The vertical bar = 1SD, n=3.
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5 . 4 .  Response to local inflammation
5.4.1. Reduced inflammation to carrageenin in mutant mice
NO is involved in the acute inflammatory response following foot pad injection of 
carrageenin (lalenti, et aL, 1992, lanaro et aL, 1994). Using the iNOS mutant mice in this 
study, the role of nitric oxide in acute inflammation was directly demonstrated. Groups of 
5 mice were injected in the right hind footpad with 300pg of lambda carrageenin in 50pl 
PBS. The control left hind footpad was injected with 50pl PBS alone. Footpad swelling 
was measured daily with a dial calliper up to six days after injection, and the data shown 
represent mean footpad thickness increase (right footpad-left footpad). The mutant mice 
generated significantly less footpad swelling than wild type mice at dayl and 2  after 
injection with carrageenin. Footpad swelling had all decreased after day 3 of injection (Fig 
5.7).
5.4.2. T cell analysis after injection with carrageenin
Spleen cells from mice injected with carrageenin were harvested at 21 days after 
injection and analysed for CD3+, CD3+ CD4+ and CD3+CD8+ subsets by flow 
cytometry using the same antibodies as described in Chapter 2 (2.45.). Spleen cells from 
mutant mice had higher proportion of CD3+, CD3+ CD4+ and CD3+CD8+ T cells than 
those from the wild type mice (Table 5.4).
Table 5.4. T-cell analysis of the mice at 21 days after injection with carrageenin
Splenic T cells (%) wild type (n=5) Homozygous (n=5)
CD3+ 19.42±1.27 39.32±0.81
CD3+CD4+ 8.91±0.44 14.69±0.94
CD3+CD8+ 2.83±0.61 9.38±1.03
*Data are mean±lS.D. Figures underlined are significantly different (P<0.05) from those 
wild-type mice.
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Fig.5.7. Footpad swelling was significant by reduced at day 2 and day 3 after 
injection with SOOpg of carrageenin in mutant mice (solid triangles) compared with 
wild-type mice (empty triangles). Vertical bar=SEM, n=5. *P=0.02; **P<0.001.
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5.4.3. Spleen cells of mutant mice had higher proliferation
Spleen cells were also pooled from 5 mice per group and cultured at 1x10^ cells 
per ml in flat bottom 96-well plates with graded concentration of ConA (0.1, 0.5, 2.5, 
and 10.0p,g/ml). Proliferation of spleen cells were measured on day 1 to 3 after 
stimulation according to the method described in Chapter 2 (2.44). Spleen cells 
proliferation of mutant mice was significantly higher than that of the wild-type mice on 
day 2 and 3 at doses of 0.5 to lO.Opg/ml ConA. The optimal proliferation of the cells 
from mutant mice was on the day 3 at 2.5pg/ml ConA, while that of the wild-type mice 
on the day 2 at 2.5p,g/ml ConA (Fig.5.8).
5.4.4. IFN-y and IL-4 produced after ConA stimulation in vitro
Supernatant of cultures was also collected on day 1 to 3 after stimulation with 
2.5pg/ml ConA in vitro . IFN-y and IL-4 levels were measured by ELISA as described in 
Chapter 2 (2.39.). Cells from the mutant mice produced significantly higher levels of 
IFN-y than those from wild type mice at all time points. Analysis of IL-4 production 
however showed no significant differences between the two groups at all time points 
tested (Fig.5.9).
5 . 5 .  Mice lacking iNOS are more resistant to LPS-induced loss of mass 
and mortality than wild type mice.
5.5.1. Reduced loss of mass during LPS-induced shock
Groups of 5 mice were injected intraperitoneally with lOmg/kg LPS in PBS. The 
wild-type mice developed severe symptoms with up to 12% loss of mass. In contrast, the 
mutant mice showed only minimum symptoms after transient loss of mass within 24 
hours, and they all recovered by 72 hours after injection (Fig5.10.a).
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Fig.5.8. Proliferation of spleen cells from carrageenin injected mutant mice (solid 
triangles) and wild-type mice (empty triangles). Cultures were incubated for 1 day (a), 
2 days (b) or 3 days (c) with graded concentrations of ConA. Cultures were stimulation 
with 2.5pg/ml of ConA (d). Verical bars=l SD, n=3.
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Fig.5.9. IFN-y and IL-4 production in carrageenin-injected mice after stimulation
with 2.5pg/ml ConA, spleen cells from mutant mice (filled columns) produced
significantly higher amount of IFN-y than wild-type mice (open columns), but no 
significant difference for IL-4 production was noted at all the time points. Vertical 
bars=lSD, n=3.
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Fig 5.10. (a.) Wild-type mice (open triangles) had more body mass loss after 
injection with lOmg/kg of LPS than mutant mice (closed triangles) *P<0.05; n=5. 
(b.) All the mutant mice survived after 12.5mg/kg of LPS, while about 45% wild- 
type mice (open triangles) survived. *P=0.16 (survival test); n=9.
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5.5.2. Mutant mice survived from endotoxin-induced shock
Groups of 9 mice were injected i.p. with 12.5mg/kg LPS, 5 of 9 wild type mice 
died within 72 hours with extensive subcutaneous haemorrhage. In contrast, all the 
mutant mice recovered from an initial transient loss of mass (Fig. 5. lO.b). All the mutant 
mice body weight recovered earlier than survived wild-type mice.
5 . 6 .  Summary
Inducible NOS gene was disrupted in embryonic stem cells which were then used 
to produce germline chimeras. FI heterozygous mice for the mutation were bred to obtain 
homozygous mice for the disrupted iNOS gene. Loss of the wild type allele was 
confirmed by Southern blotting which was described in Chapter 4. Homozygous animals 
were viable and fertile, and there was no evidence of histopathology within the major 
organs examined (The histological examinations for three mice in each groups were 
carried out by Dr. G. Lindop, The Department of pathology. Western Infirmary, 
University of Glasgow). Inter-breeding of mutant mice gave rise to a stock of mice that 
were used for the following experiments. Some of biological phenotypes were defined by 
the homozygous mice, which were compared with sex- and age- matched animals of wild 
type mice or heterozygous mice.
Spleen cells from unimmunized mutant mice gave similar levels of IFN-y and IL-4 
production compared with those from the wild-type mice when induced with concanavalin 
A and also proliferated to the same degree. There was also no difference in the proportion 
of T cells between the two groups.
The wild-type mice and the heterozygous mice were highly resistant to L. major 
infection, and all animals achieved spontaneous healing after footpad infection with 1 0  ^
promastigotes. In contrast, the mutant mice were highly susceptible to the infection and 
developed visceral disease by day 70 post-infection. There was no significant difference 
in lesion size between the three groups of mice until 5 weeks after infection, indicating 
that the innate response, possibly under the influence of the Natural resistance associated
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macrophage protein {Nramp) gene, is unlikely to be associated with the NO effector 
mechanism. Nramp is believed as one of the control gene for natural resistance to 
infection with intracellular parasites (it will be explained more in Chapter 6.4.).
Spleen cells from mutant mice infected with L. major contained a significantly 
higher proportion of CD3+ and CD3+CD4+ T cells than those from the infected wild type 
and heterozygous mice. Spleen cells from the infected mutant mice also showed 
significantly higher levels of T-cell proliferation than those from the wild-type or 
heterozygous mice when cultured with Leishmania antigens or concanavalin A in vitro. 
They produced more IFN-y, but less IL-4 than those from similarly infected wild-type or 
heterozygous mice when stimulated with soluble Leishmania antigens in vitro. Anti- 
Lei shmania antibody titres were comparable in all the three groups of mice, but the 
concentrations of IgG2a were greater than those of IgGl.
The capacity of these mice to develop local inflammation was also investigated. 
The mutant mice generated significantly less footpad swelling than wild-type mice after 
injection with carrageenin. Spleen cells from carrageenin-treated mutant mice also had a 
higher proportion of CD3+, CD3+CD4+ and CD3+CD8+ T cells than those from the 
wild-type mice, and produced more IFN-y than those from the wild-type mice when 
stimulated with concanavalin A in vitro. The spleen cells from the mutant mice treated 
with carrageenin had a higher proliferation rate than those from the wild-type mice. 
However, the relatively lower proliferation of the wild type spleen cells at day 21 after the 
carrageenin stimulation suggests that higher NO production could suppress the T-cell 
response to the ConA.
The mutant mice were also more resistant to LPS-induced death than wild-type 
mice, which developed severe loss of mass when injected intraperitoneally with LPS. The 
mutant mice showed an initial malaise and loss of mass, but recovered completely by 24 
hours, and showed no further sign of ill health. In contrast, wild-type mice underwent 
substantial loss of mass with about 50% mortality by 72 hours after injection with 12.5 
mg/kg body mass.
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Mice deficient in iNOS provide a powerful tool that will not only facilitate formal 
demonstration of the effect roles of NO in microbicidal, tumoricidal, transplantation and 
in a range of immunopathologies, but also help to define the involvement of NO in 
immune regulation, immunological tolerance and antigen processing and presentation. 
This is highlighted by the recent demonstration that human monocyte / macrophages 
express iNOS (Mossalayi, et al., 1994; De-Maria, et at., 1994.) and generate NO in 
quantities sufficient to kill Leishmania parasites (Vouldoukis, et at., in press).
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Chapter 6
General Discussion
141
The development of gene targeting technology, through homologous 
recombination between exogenous DNA and the endogenous genomic homologue in 
mouse embryonic stem (ES) cells, provides a powerful tool for generating mutant mouse 
strains with defined genetic modifications. These animal models allow us to study the 
functions of the targeted genes in vivo. The technology is especially attractive for 
studying genes specific for immune responses, since the modification of these genes is 
unlikely to be lethal to embryo development of the mutant mice. In this study, iNOS gene 
mutant mice were made by using the ES cell gene targeting technology. In this chapter, a 
number of points will be addressed. (1). 5' iNOS gene organisation. (2). Optimum gene 
targeting strategy. (3). Mutation that may occur by gene rearrangement events. (4). 
Explanations of iNOS biological phenotype. (5). Conclusion and future works.
6 . 1 .  5' murine INOS gene structural organisation
To design the iNOS gene target construct, 5' end of cDNA fragment was used as 
probe to clone the genomic DNA. Four overlapping iNOS gene clones were obtained 
from two mouse strain genomic libraries. The restriction enzymes {EcoRl, BamHl, 
HindUl, Bglll, Kpnl, Sad, Pstl, Sm d, Spd, Xbal) mapping for the DNA from both 
strain is exactly identical. Although no difference was found for the restriction enzymes 
mapping between 129/sv and B6  strains, Possible variations outside of the enzyme sites 
could largely reduce the efficient homologous recombination (Riele, et aL, 1992).
The first eight exons were located in these four overlapping genomic clones. They 
span over 21kb of cloned DNA. Intron-exon junctions were sequenced for six of the eight 
exons (Exons 1,2,3,4,5,7). Most of them conformed to the Mount consensus for spliced 
junction sequences (3' Acceptor: (Y)nNYAG; 5' Donor: GTRAGT)(Chapter4.2). Murine 
iNOS exons (exons 1 to 8 ) were found to be structurally similar to the human iNOS gene. 
All the eight exons which have been identified in the present study are small. Unlike 
human iNOS has a large intron 5 (about 6 kb), murine iNOS has a large intron 2 which is 
about 5.5kb. However, the start codon (ATG) is located in exon 2 which is the same as 
human iNOS and ncNOS gene (Chartrain, et al. 1994; Hall, et al., 1994).
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6 . 2 ,  Optimum gene targeting strategy.
6.2.1. Maximising efficient homologous recombination
Homologous recombination between transferred DNA and the chromosomal gene, 
termed gene targeting, provides a way of making specific alterations in the genome. In 
mammalian cells, integration of transferred DNA into the chromosomes occurs much 
more frequently by nonhomologous than by homologous recombination, an effect that 
impedes the detection and recovery of the rare targeted cells (Capecchi, 1989; Deng, et 
al., 1992,). The mechanism of the homologous recombination is not well known. Many 
experiments have been carried out to investigate the strategies which can influence the 
efficiency of homologous recombination. Although different gene loci may have different 
recombination efficiency, these investigations could help gene targeting design.
Length of homologous region. The homologous sequences in the vector, 
specifically their length (Thomas, etal., 1987; Hasty, et al., 1991) and the degree of 
polymorphic variation between the vector and the chromosome (Riele, et al., 1992), have 
been shown to affect targeting frequencies. As a general rule, the greater the length of 
homology the higher the targeting frequency. For most vectors, the range of five to ten 
kilobases is recommended. In the iNOS gene targeting vector, the length of homology is 
about 6.5kb (left arm: 3.0kb plus right arm: 3.5kb). The asymmetry homology arm for 
the PCR screening strategy can also have an effect on the targeting frequency, since the 
length of the short arm may become suboptimal, although cross-over have been observed 
to occur with less than 500bp on the short arm (Hasty, et a l, 1991).
Isogenic gene construct. It is known from studies on extra-chromosomal and 
intra-chromosomal recombination, and recently, from gene targeting experiments (Riele, 
et a l, 1992), that a significant variation in sequence homology between the two elements 
involved in the genetic exchange can reduce homologous recombination/targeting 
frequency. The number and extent of polymorphic variations between two mouse strains 
in any given locus is unknown but may vary widely from gene to gene. In particular.
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Vector cutting out in homologous region. Enzyme cutting in both homology 
regions can enhance the efficiency of homologous recombination by 3-4 times compared
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introns are likely to be more divergent than exonic sequences. To avoid gene variation 
between B6  and 129/sv mice, iNOS gene targeting construct was generated from 129/sv 
ES cells genomic DNA.
Gene transcription in ES cells. Much direct and indirect evidence has shown that 
transcription enhances homologous recombination in mammalian cells (Nickoloff, et al., 
1992; Johnson, et al., 1989; Mansour, et al., 1988; Nickoloff, et al., 1990; Shenkar, et 
al. 1991). Before designing the iNOS gene targeting constructs, attempts were made to 
detect iNOS gene expression by measuring nitrite from supernatant of ES culture and by 
using RT-PCR. No detectable iNOS gene expression was found in the ES cells, even 
after stimulation with IFN-y and LPS which can induce iNOS gene expression in murine 
macrophages. The low efficient homologous recombination events in this iNOS gene 
targeting (one in 636 G418 resistant clones screened) may be due to the fact that iNOS 
gene is tightly controlled in the ES cell.
Size of deletion. The gene targeting frequencies and recombination products 
generated have been investigated by a series of replacement deletion vectors which target 
the hprt (hypoxanthine phosphoribosyltransferase) locus in the mouse ES cells (Zhang, et 
al., 1994). The efficiency of homologous recombination was apparently not influenced by 
the size of deletion for the disrupted gene, however the different integration was 
demonstrated in the large deletion vector targeting. In this study, the replacement vector 
used was by deletion of 11.5kb from the first 5 exons and part of promoter of iNOS 
gene. As described in Chapter 4.5, Southern blotting with both 5' and 3’ end specific 
external probes was consistent with a gene replacement event. But the replaced wild type 
gene appeared to have translocated and integrated in the gene locus identified by the 
EcoRV digested Southern blot. The precise integration pathway is at present unclear
because of the limited mapping of the iNOS gene. The possibilities of the gene 
rearrangement will be described below.
i
to a cut in one homologous region alone (personal communication with M. Li. Gene 
Targeting Laboratory, Centre for Genome Research, University of Edinburgh.). In this 
study, 6 'ncl was used to linearise the targeting construct to expose both the 5' and the 3' 
homology regions.
6.2.2. Enrichment for targeted clones in culture
Gene trap strategy. Using selection markers in the targeting construct can enrich 
the targeted clones in culture. However, they could not influence the efficiency of 
homologous recombination. Promoter trap targeting vectors are designed to use the 
transcriptional machinery of the endogenous target gene to drive the positive selection 
cassette cloned in the targeting construct. Typically, promoter trap selection will yield an 
enrichment of about 100-fold for targeted clones. In some gene targeting experiments, 
8 6 % targeted clones has been generated from G418 resistance CGR8  ES cell clones 
(Mountford, et aL, 1994). However, good candidate genes for this selection scheme are 
those gene expression in the target cell. In this study, the iNOS gene expression has not 
been detected in the ES cells. The iNOS gene is probably too big for the polyadenylation 
trap targeting strategy and is therefore not suitable for this study.
Positive and negative selection. Positive and negative selection is commonly used 
for enrichment scheme. The idea is that a targeting construct is designed to contain the 
neomycin resistance gene cassette encoding for resistance to geneticin for positive 
selection. In addition, the construct may contain an HSV-tk gene for negative selection, 
which is capable of converting Ganciclovir into toxic intermediaries. Cells that undergo 
homologous recombination are Ganciclovir and G418-resistant. Cells which contain the 
randomly integrated construct will retain both the neomycin and HSV-tk genes and 
although G418-resistant, will be Ganciclovir sensitive (Mansour, et al., 1988). In the 
present iNOS gene target, we exposed both homology ends to enhance targeting 
efficiency. A positive selection marker can not be used, because Sad  will cut the positive 
selection marker (HSV-tk gene) off. Although only the positive selection marker {Neo 
gene) was used in the iNOS gene targeting strategy, the efficiency of homologous
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recombination (1/636) was not as low as the positive and negative selection strategy 
(1/980) which was used in the same gene locus of the iNOS gene targeting (Macmicking, 
et aL, 1995). The low ratio of targeted gene may due to the characteristice of iNOS gene 
locus.
6 . 3 ,  The iNOS gene mutation
6.3.1. iNOS gene is not duplicated in wild-type mice
Using both 5' and 3' specific external probes, two hybridisation bands (7.0kb 
wild-type band and 5.4kb targeted band for 5' probe; 7.5kb wild-type band and 6.0kb 
targeted band for 3' probe) were always detected in the homozygous mice. Unlike the 
heterozygous mice, the band densities were equal. In heterozygous mice, wild-type 
bands for both external probes were more dense than the targeted bands. But the genotype 
was difficult to identify with Southern blot analysis using the external probes. This result 
suggested that there may be duplicated iNOS gene in the wild-type mice, one of them had 
been replaced with the targeting vector and the other persisted. To test this possibility, 
genomic DNA from ES cells and three genotype mice tail tippings were digested with 
enzymes with restrictive sites in the targeting vector homology region. If the duplicate 
genes are not exactly identical. Southern blot with 5' or 3' external probe should show 
double band in all of them. However, the result showed that the duplicated bands were 
only obtained with DNA from the homozygous and heterozygous mice and not from that 
of the wild-type mice or ES cell. This result therefore indicated that it is unlikely that there 
is duplication of iNOS gene in the wild-type mice.
6.3.2. End extension of the targeting construct
To study the mechanism of targeted recombination, a wild-type gene was 
introduced into a mutant Chinese Hamster Ovary (CHO) cell line which is homozygous 
adenine phosphoribosyl transferase (APRT) deficient. The truncated end of the aprt gene 
was corrected by extending the end beyond the region of homology to the target locus 
(Aratani, et aL, 1992). In the present study. Southern blot analysis, using both the
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Two gene altered events can be identified by using internal and external probes for 
Southern blot analysis. These two genotypes could not be segregated by back-crossing
6.3.4. The larger mutant mRNA
Using 973bp 5' iNOS cDNA probe for Northern blot analysis, the 4.0kb iNOS 
mRNA was also shown to be altered to 4.5kb in the mutant homozygous mice. The 
possibilities of gene rearrangements (b, c and d described in 6.3.3.) can lead to the 
transcription of larger messenger. The end extension targeting vector integrating into the
external probes, indicated that the introduced targeting vector had entered the gene locus.
Furthermore, extension from both ends which had resulted in the gene duplication 
(Fig.6.1).
6.3.3. Targeted iNOS gene
The limited map of the iNOS gene from this study makes it difficulty to 
understand the genetic events in the gene targeted mice. So far, we know that end
■ ■
extension had occurred (Fig.6.1), which either caused end extension targeting vector 
integration or wild-type genomic DNA integration. There are four possibilities, (a) The 
end extension targeting vector was randomly integrated. This should not make any change 
for wild-type allele, (b) The end extension targeting vector had integrated into the iNOS 
gene, (c) The wild-type genomic DNA was randomly integrated or (d) into the iNOS gene 
locus. Any of these events can result in iNOS gene mutation except (a). However 
Southern blot analysis with EcoRW digested DNA using internal probe showed that the 
12kb wild-type band was replaced by a 14kb band in the homozygous mice. This result 
indicated that it is unlikely that (a) had occurred.
experiments. This may indicated that both the recombination events had occurred in the 
iNOS gene locus. To demonstrate the precise iNOS gene targeted events in this strain of
mice, the large region of wild-type and mutant iNOS genome will have to be mapped. 
This will be discussed in the section on future work (6.7.1.).
I
I
iNOS gene, or the 5' iNOS genomic DNA integrating into up-stream targeted gene could
'
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cause some exons duplication. Transcription might go through the whole targeted gene 
resulting in a large messenger with duplicated part of sequence in the middle of the 
messenger (Fig. 6.2). The other possibility for the larger messenger is that part of iNOS 
genomic DNA had integrated into another gene (X gene) locus (fig. 6.3). This integration 
event might resulting in a fusion messenger, since a part of iNOS genomic DNA might 
still contain a functional promoter which could switch gene transcription after induction 
by IFN-y and LPS. However, this integration event detected by internal probe, and the 
gene replacement targeting event detected by external probe, could not be segregated in 
the offspring from back-crossing breedings. This result was obtained by Southern blot 
analysis of DNA from 92 offsprings. Two events in the same gene locus appeared to be 
more likely.
6.3.5. Abrogation of iNOS protein translation
Although the larger messenger was detectable by Northern blot analysis in the 
peritoneal macrophages at 6  hour after IFN-y and LPS induction, no iNOS protein was 
detectable up to 20 hours after induction by Western blot analysis (ECL system) with 
either monoclonal or polyclonal iNOS specific antibodies. This result may indicate that the 
larger mutant messenger was either in incorrect reading frame or unstable for translation 
of iNOS protein.
6.3.6 . Detectable Nitrite production after longer culture
Nitrite was measured by Griess method up to 6  days for the culture supernatants 
from the activated peritoneal macrophages. After 24 hours activation, a large amount of 
nitrite was detected in cell culture of peritoneal macrophages from the wild-type and 
heterozygous mice. However, no detectable nitrite production was found at 24 hours 
from homozygous mice, in some experiments even no nitrite production till 4 days after 
activation. For most cases, however, nitrite could be detectable by 72 hours after 
stimulation, but not in control unstimulated cell culture. It is known that macrophages 
have two forms of NOS, one is calcium-independent (iNOS) and the other is calcium
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dependent (ncNOS and ecNOS). In J774 macrophage cell line, both iNOS and cNOS 
activities are increased markedly by LPS stimulation (Dusting, et al., 1995). The nitrite 
production from iNOS mutant mice may either come from up-regulation of constitutive 
NOS or the other form of yet unidentified NOS,
6 . 4 .  The role of iNOS in immunology defence
6.4.1. iNOS is important against leishmania infection
There is increasing evidence that NO from iNOS plays a key role in nonspecific 
defence mechanisms against pathogens, and may be involved in the signalling between 
macrophages and T cells. CD4+ T helper (Th) cells which are critical in host defence have 
been implicated in chronic inflammatory diseases. Two types of Th cell are distinguished 
by the pattern of cytokines secreted upon activation. Thl cells release IL-2 and IFN-y, 
whereas Th2 cells produce IL-4, IL-5 and lL-10 (Mosmann, et al., 1989), These patterns 
of cytokine production largely determine the effector functions of the two subsets of 
murine and human T cells (Romagnani, 1991). The Thl and Th2 subsets also modulate 
each other’s activity in such a way that the balance between them frequently determines 
the outcome of infectious and autoimmune diseases. IFN-y produced by Thl cells 
promotes the differentiation of T-cell precursors (ThO cells) to Thl cells, and inhibits the 
proliferation of Th2 cells. By contrast, lL-4 produced by Th2 cells can drive the 
proliferation of Th2 cells, and lL-10 can indirectly inhibit the secretion of IFN-y by Thl 
cells (Fitch, et a/., 1993). NO may balance these two subsets of Th cells.
Experimental leishmania infection in the murine model has been well established, 
especially for cell-mediated immunity (Liew, 1990). A large amount of evidence supports 
the notion that Thl dominant will be protective against L. major infection (Scott, et al., 
1988; Holaday, et al., 1991; Morris, et a/.,1993). One of the mechanisms is that IFN-y 
produced by Thl cell actives macrophages to produce NO, which is toxic to the parasites. 
Mouse peritoneal macrophages stimulated in vitro with IFN-y in the presence of LPS are 
efficient in killing leishmania and this leishmanicidal activity can be completely blocked by
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L-NMMA in a dose-dependent manner, but not by its D-enotiomer (D-NMMA) (Green, et 
a /.,1990; Liew, etaU, 1990).
To define the iNOS functions in vivo, the iNOS gene mutant homozygous mice as 
well as the control heterozygous and wild-type mice were infected with L. major. The 
wild-type and the heterozygous mice were highly resistant to L. major infection, and all 
animals achieved spontaneous healing by contrast, the iNOS mutant mice were highly 
susceptible to the infection and developed visceral disease by 70 days postinfection. The 
parasite load was 1,0(X) times higher in the footpad of the homozygous mice than in that 
of the wild-type or heterozygous mice.
T cells were analysed for the three groups of infected mice. Spleen cells from 
homozygous mice had higher proliferative response to Con A and also to leishmania 
antigen than those from wild-type or heterozygous mice. Percent of CD4+ T cells (T 
helper cells) was also significantly higher in infected homozygous mice than in the wild- 
type or heterozygous mice. In the T helper cells populations. The ratio of Thl/Th2 was 
higher in the mutant mice than in the wild-type or the heterozygous cells, because their 
spleen cells produced higher concentration of IFN-y and lower levels of IL-4 compared to 
those from the wild-type or heterozygous control. It seems that the cell-mediated 
immunity in the homozygous mice worked very hard to protect the host against 
leishmania infection, but without the weapon (NO) to do so. This result provides a direct 
evident that iNOS is important for the host defence leishmania infection in vivo.
6.4.2. Possible mechanisms of the altered immune response in iNOS mutant mice
NO from activated macrophages could kill the leishmania and macrophages 
themselves. Substantial amounts of NO produced from iNOS kill parasites efficiently, at 
the same time, it can also killed activated macrophages. Activated macrophages produce 
cytokines such as IL-12 which can push ThO cells to Thl cells. The Thl then produce 
more IFN-y to active the macrophages to produce more iNOS and NO to kill the parasites i
even more efficiently. When the parasite was killed, the antigen-specific T cells go down
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to normal level. However, in the mutant mice, activated macrophages could not kill the 
parasites, and also many macrophages continued to be activated. These macrophages 
could produce more IL-12 to drive Thl cell development, and the leishmania antigen 
could also continue to activate T cells.
NO from iNOS may directly inhibit the T cell activitv. Substantial amount of NO 
produced from iNOS may inhibit the T cell activity, especially for Thl cells. Hoffman et 
al, 1990, first reported that NOS activity was detected during phytohaemagglutinin 
(PHA)-stimulated proliferation of rat spleen cells and also in mixed lymphocyte 
responses, and that the addition of NOS inhibitor, L-N^ monomethyl arginine 
(LNMMA), to the cultures suppressed NOS activity and allowed a robust proliferation 
response to occur. These findings have since been extended to both in vitro and in vivo 
murine models, indicating that NO inhibits the proliferation of T cells. Macrophage 
activation in experimental murine trypanosomiasis induces the release of NO, which 
down regulates the proliferative response of T cells during infection (Sternberg, et aL, 
1992; schleifer, et aL, 1993). Results from the present study indicated that T cell activity 
is enhanced by the absence of large amounts of NO production from iNOS.
NO from iNOS in endothelial cells may be involved in defence. Without iNOS 
production from endothelial cells, endothelial cells might not be activated during the 
infection. The activated T cell might not migrate to the infected tissue to help killing the 
parasite, Thus, antigen specific T cells continued to expand in the circulation and 
peripheral lymphoid organs. That may also explain the low inflammation for the 
carageenan and small footpad swelling in the early stage of Leishmania infection.
6.4.3. iNOS may not be involved in parasite growth control of the Nr amp gene .
The ability of a host to resist infection with a wide range of viral, bacterial, and 
parasitic pathogens is strongly influenced by genetic factors (reviewed by Skamene, 
1985). In the mouse, infection with leishmania is biphasic, with an early non-immune 
phase (0-3 weeks) characterised by rapid proliferation of the pathogen of susceptible
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strains and absence of parasite growth in resistant strains. The late phase (3-6 weeks) is 
associated with specific immune response, leading either to clearance of the pathogen load 
or to persistent infection in the tissue of the susceptible strains. While the late phase of 
infection is under control of genes linked to the major histocompatibility complex, the 
difference in innate susceptibility detected in the early phase is controlled by the 
expression of a single dominant gene in chromosome 1. One of the transcription units in 
this gene has been cloned as Nramp (Nature resistance associated macrophage protein, 
Vidal, etal., 1993)
Nramp is isolated from a group of genes (Lsh/Ity/Bcg) controlling the priming 
activation of macrophages for leishmania, Salmanella and mycobacterium infection. 
Nramp encodes a poly topic integral membrane protein that has structural features common 
to prokaryotic and eukargotic transporters and includes a conserved binding-protein- 
dependent transport motif which may be involved in interaction with peripheral ATP- 
binding subunits. The N-terminal sequence also carries a proline/serine rich putative SH3 
binding domain, consistent with a role for tyrosine kinases in regulating Nramp function 
of P i integrins, which signal via tyrosine kinases. Transfection studies with the resistant 
allele demonstrated that Nramp also plays a role, either directly or as an additional 
pleiotropic effect, in IFN-y/LPS upregulated L-arginine transport across the macrophage 
membrane, thus providing the substrate required to generate NO for both signal 
transduction and anti-microbial activity (Blackwell, et al, 1994). The present study 
showed that there was no difference in the size of the footpads till five weeks after 
infection. This may indicate that Nramp is not involved in the NO production from 
iNOS.
6 . 5 .  The roles of iNOS in acute inflammation and LPS-indueed death
In the present study, carageenin was injected into the footpads of wild-type and 
homozygous mice to induce acute inflammation. The result suggested that iNOS was 
involved in local inflammation. This result also confirmed the result from an early study 
using L-NMMA to inhibit NO production (lanaro, et al,, 1994). However, spleen cells
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from mutant mice, stimulated with Con A, had a higher proliferative response and INF-y 
production than those from wild-type mice at the 21 days post-treatment. The result from 
using L-NMMA showed a decrease in IFN-y production in the T cells of DLN (draining 
lymph node ) which were removed at the peak of the inflammatory response. In the 
present study, however, the spleen cell response was examined at 2 1  days after 
inflammation and NO may act at a different stage of inflammation and on T cells at a 
different location.
In the present study, the LPS-induced death was also tested for the homozygous 
mice and the wild-type mice. About 50% of wild-type mice died after 3 days of the 
injection with 12.5mg/kg of LPS, while none of the iNOS mutant mice died. The result 
suggested that iNOS was involved in LPS-induced death. The other reported iNOS 
mutant mice were also resistant to LPS-induced death under anaesthesia (MacMicking et 
al. 1995). However, unanaesthetised iNOS mutant mice suffered as much LPS-induced 
liver damage as wild-type mice. These authers suggested that there exist both iNOS- 
dependent and iNOS-independent routes to LPS induced hypotension and death. The 
difference between the two iNOS mutant mice in response to LPS-induced shock may be 
due to the different gene back ground of the two strains of mice. The outbred mice (MFl) 
which were used in our study may be more resistant to the liver damage of the LPS- 
induced shock than the inbred mice (129/sv) reported by MacMicking et al. (1995).
6 . 6 .  Conclusions
Results from the present study show that although iNOS can be induced in nearly 
every cell type, the animal is viable without iNOS in the mutant mice. This may be the 
result of redundant functions of the other isoform of NOS. However, iNOS or NO 
production from iNOS is involved in the host defence against parasite infection and in 
regulating cell-mediated immunity in vivo when the immune system is activated by 
pathogens. iNOS is also involved in the LPS-induced death and the acute inflammation.
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The iNOS mutant mice, provide a useful tool that will not only facilitate formal 
demonstration of the effector roles of NO in microbicidal, tumoricidal, transplantation and 
in a range of immunopathologies, but also help to define the involvement of NO in 
immune regulation, immunological tolerance and antigen processing and presentation.
6 . 7 .  Future work for the iNOS mutant mice
6.7.1 Analysis of recombination events
Although the iNOS expression is disrupted by the iNOS gene targeting in the 
present study, there appears not to be a straight forward deletion of exons 1-5 as 
intended, but an insertion and translocation of the disrupted iNOS gene. This could be a 
unique hitherto unreported recombination event which could have a fundamental influence 
on gene-targeting technology. The following work may be carried out:
In the construction of the iNOS-deficient mice, about 21 kb iNOS genomic DNA 
(containing 8  exons contributing to 937 of the 4117bp iNOS mRNA) was cloned from B6  
and 129/sv mice genomic libraries, Genomic libraries from both wild-type and mutant 
mice can be screened with the following probes: 5' and 3' end iNOS gene-specific probes 
(used for screening iNOS gene targeting events), iNOS cDNA probe, and neo gene 
probe. The cloning genomic DNA from the two strains could then be mapped and 
compared to find the exact mutation point. If the translocation occurred far away from the 
wild-type iNOS gene locus, pulse field gel or even fluorescence in situ hybridisation may 
be used to locate it.
6.7.2 Human iNOS (hiNOS) transgenic mice
The result from this study shown that iNOS plays a crucial role as a mediator of 
inflammation and as a key agent in LPS-induced death. Thus, inhibitors which are highly 
specific and selective for human iNOS could potentially be of great therapeutic value for 
some of the most important immunopathologies. Introduce human iNOS gene into the
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iNOS-deficient mice and the resultant human iNOS transgenic mice would be extremely 
valuable for the rational screening of human iNOS-specific inhibitory compounds.
Human iNOS cDNA can be driven by the murine iNOS promoter which has been 
cloned in our laboratory. Full length human iNOS cDNA with murine iNOS promoter can 
be constructed together with selection marker gene cassette, p-actin-Meo gene. The 
construct can then be transfected into a murine cell line (J774 or Raw), and transfectants 
selected in medium containing G418. Expression of hiNOS can then be ascertained by 
stimulating the G418-resistant cells with IFN-y and LPS, and detected by Western blot 
with anti-human iNOS specific antibody or Northern blot with a human iNOS specific 
cDNA probe. The successful constructs can then be injected into fertilised eggs from 
homozygous iNOS -deficient mice. Copies of the transfected gene can be analysed by 
Southern blot using the neo gene probe or hiNOS cDNA probe to hybridise the restriction 
enzymes digested DNA extracted from tail clips. Western and Northern blots can then be 
used to identify expression of hiNOS in the peritoneal macrophages from homozygous 
transgenic mice. This approach, though more straight forward, may result in a strain of 
hiNOS transgenic mice whose iNOS expression will be significantly different from that of 
the wild-type mice. This is because the nature of the regulatory elements upstream of the 
iNOS promoter is not yet defined.
An alternative strategy would be to create a functional hiNOS gene replacement 
construct, using the murine iNOS promoter as the 5' homologous arm followed by 
hiNOS cDNA, selection marker neo gene cassette and the 3' homologous arm. Functional 
expression of the construct can be tested as above. Successful constructs can then be 
transfected into ES cells and recombinants detected by PCR or Southern blot. The ES cell 
line with hiNOS can then be injected into the blastocysts to generate chimeras as described 
earlier. Heterozygous from germ line transmission chimeras can then be bred to generate 
homozygous hiNOS transgenic mice with full of regulation area (including Promoter, 
repressor and enhancer) and thus may retain the level of iNOS expression akin to the 
murine system.
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These mice can then be used to screen a panel of candidate compounds which are 
being prepared by a number of pharmaceutical houses. Initially, the LPS-induced death 
and carrageenin-induced inflammation models can be used. These two modes are well- 
established.
6.7.3. Phenotypic analysis of iNOS deficient mice
So far, using the iNOS gene targeted mice, we have established the critical role of 
NO in leishmanial infection, local inflammation and endotoxin-induced death. However, 
the precise mechanisms mediated by NO in these diseases are unknown. The cytokine and 
cellular profiles induced in the iNOS-deficient mice following carageenin or LPS injection 
can be closely monitored with respect to dose-response and kinetics. The role of NO in 
the production of cytokines such as TNF-a, IL-ip, IL-6 , ÎL-8 , IL-12 and ÏL-I5 can be 
determined in vivo and in vitro.
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